Latest / Drawn of History / Dr. Peter McCullough _ This Past Weekend w_ Theo Von _647(M4A_128K)
Transcript
- 0:00Speaker 1: Just a reminder that tickets for Busboys, the movie, with
- 0:05Speaker 1: myself and David Spade are on sale right now, pre-sale tickets.
- 0:10Speaker 1: You can get them. It's in theaters April 17th. But
- 0:14Speaker 1: if you get tickets now, it'll show the movie theaters
- 0:16Speaker 1: that we're going to sell them or that they are selling,
- 0:19Speaker 1: and then we can expand to more theaters. So if
- 0:23Speaker 1: you know when you're going to go and you can support,
- 0:26Speaker 1: that would be great. And no pressure if you can't. Again,
- 0:30Speaker 1: the pre-sale tickets are available. Busboysmovie.com. I'm excited. Thank you.
- 0:37Speaker 1: Today's guest is a physician. He's a cardiologist. He's an author.
- 0:41Speaker 1: He's a professor. He was the vice chief of internal
- 0:45Speaker 1: medicine at Baylor University Medical Center. He later became known
- 0:49Speaker 1: for his investigations online. into the COVID-19 response here in America.
- 0:55Speaker 1: We're looking forward to spending time with today's guest, Dr.
- 0:59Speaker 1: Peter McCullough.
- 1:05Speaker 2: I love this guy.
- 1:17Speaker 1: And you can move this any way you want. If
- 1:18Speaker 1: you decide you're moving over here, you can just move
- 1:20Speaker 1: the mic over there.
- 1:20Speaker 2: I don't have the type of voice you have. Get
- 1:23Speaker 2: that deep voice.
- 1:24Speaker 1: We'll make sure. We'll let you know if it's off. Okay. Yeah,
- 1:27Speaker 1: you're kind of that whisperer, huh?
- 1:29Speaker 2: Man, well.
- 1:30Speaker 1: You like to whisper?
- 1:31Speaker 2: I was recently in the UK, and this woman who's
- 1:33Speaker 2: an actress got up, and everyone was shouting at the microphone,
- 1:37Speaker 2: making their things, myself included. She got up, and she
- 1:41Speaker 2: started whispering, and everyone paid attention.
- 1:46Speaker 1: Yeah, that's a whisper, and it's a lost art. Yeah.
- 1:49Speaker 1: But really the value, when everything is so high, you
- 1:52Speaker 1: have to think that if you come in at another intonation,
- 1:54Speaker 1: if you come in at another level, you have to
- 1:56Speaker 1: find an alternate route into people's brains and hearts and stuff.
- 2:00Speaker 1: And yeah, whispering, gosh. If we had just like Whisper
- 2:04Speaker 1: Tuesdays where everybody just whispered.
- 2:06Speaker 2: There was a doctor at Stanford back when I was
- 2:10Speaker 2: accepted in academia. His name was Glenn Chertow, and when
- 2:14Speaker 2: he spoke— It was so careful, and he talked like this.
- 2:19Speaker 2: And I remember the sponsors of a big meeting. I
- 2:21Speaker 2: was at the National Institutes of Health. I said, what
- 2:25Speaker 2: is it about Glenn Chertow? He seems to be getting
- 2:28Speaker 2: all the attention. They said, he appears wise. He has
- 2:34Speaker 2: the appearance of wisdom. The way he speaks. He may
- 2:38Speaker 2: not be wise.
- 2:38Speaker 1: Right.
- 2:39Speaker 2: But he appears wise. The other thing that helps you
- 2:43Speaker 2: that you and I don't have. Oh, he brought him up.
- 2:45Speaker 2: There's Glenn right there.
- 2:46Speaker 1: There he is.
- 2:46Speaker 2: Beautiful guy. Good, good, good. Are we going to bring
- 2:48Speaker 2: people up on the screen?
- 2:50Speaker 1: We can.
- 2:50Speaker 2: Oh, this is going to be so much fun.
- 2:52Speaker 1: Oh, yeah.
- 2:52Speaker 2: But anyhow, the one thing that my Uncle Ivan taught
- 2:58Speaker 2: me is that you can double your perceived intelligence with
- 3:03Speaker 2: a British accent.
- 3:04Speaker 1: Really? Yeah.
- 3:05Speaker 2: Oh, yeah. You get a British accent, they think you're
- 3:08Speaker 2: twice as smart as you used to be. Oh, that's
- 3:09Speaker 2: so true. Twice as smart.
- 3:11Speaker 1: I feel like, oh, if I meet a British girl,
- 3:12Speaker 1: I'm like, oh, tell me everything. I feel like they
- 3:14Speaker 1: just know everything. Yes. Read me a book, mom.
- 3:18Speaker 2: Have you ever read that book, Culture Code?
- 3:21Speaker 1: Oh, Culture Code, no.
- 3:22Speaker 2: It's about what's your first impression? And he did focus groups.
- 3:26Speaker 2: It's very scientifically very solid. He said, when you meet
- 3:29Speaker 2: a British person, what's the first word that comes into
- 3:32Speaker 2: your mind?
- 3:33Speaker 1: G'day. G'day. Oh, that's Australian.
- 3:36Speaker 2: You almost got it with that girl.
- 3:38Speaker 1: Classy. Classy.
- 3:40Speaker 2: So if you're going to advertise something to the British,
- 3:45Speaker 2: you have to show somebody playing polo, and it has
- 3:48Speaker 2: to be classy.
- 3:49Speaker 1: Yes. Just finishing a biscuit, you know?
- 3:51Speaker 2: So how about Italian? What's the first thing you think
- 3:54Speaker 2: about when you see it?
- 3:55Speaker 1: Hey! You know?
- 3:56Speaker 2: The Italian first thing? The culture code says artiste. So
- 4:01Speaker 2: you have to Michelangelo. You have to portray things artistic,
- 4:04Speaker 2: what have you. how about American? Now, if you just
- 4:08Speaker 2: do this globally, when you.
- 4:10Speaker 1: Like a belch, kind of?
- 4:12Speaker 2: Oh, close. America, the conclusion is out of this world.
- 4:19Speaker 2: So you want to advertise an American like landing on
- 4:23Speaker 2: the moon or just doing something completely, you know, Elon Musk,
- 4:26Speaker 2: you know, just jetting somewhere.
- 4:28Speaker 1: Yeah, just knocking up people and just blasting rockets into
- 4:31Speaker 1: people and into space.
- 4:32Speaker 2: So culture code is a code of advertising. And what
- 4:37Speaker 2: he said is if you break the code, if you
- 4:39Speaker 2: try to advertise something that goes against what people are thinking,
- 4:43Speaker 2: your product is going to bomb out. So what's the
- 4:49Speaker 2: culture code word for nurse?
- 4:54Speaker 1: Nurse.
- 4:54Speaker 2: What's the first thing that comes to your mind?
- 4:55Speaker 1: Helpful. Close.
- 4:58Speaker 2: Mother. So you always want to show a nurse holding
- 5:00Speaker 2: a baby. What's the culture code for doctor?
- 5:06Speaker 1: Information.
- 5:08Speaker 2: Hero.
- 5:09Speaker 1: Hero. Hero.
- 5:11Speaker 2: You know, hero, going to save your life. Culture Co.
- 5:15Speaker 2: was written, I think, in the 80s or 90s. It's
- 5:16Speaker 2: probably changed. Well, here's another one. Fits for COVID. What's
- 5:20Speaker 2: the first thing that comes to your mind when you
- 5:22Speaker 2: think of hospital?
- 5:25Speaker 1: Safety.
- 5:27Speaker 2: Death trap. Death trap. And he interviewed. Hundreds and hundreds
- 5:32Speaker 2: of people did these focus groups.
- 5:33Speaker 1: Culture code.
- 5:34Speaker 2: Culture code. It's a great book. It's a quick read.
- 5:38Speaker 2: And in your business, you'd want to, I guess, kind
- 5:45Speaker 2: of be in tune with the code.
- 5:48Speaker 1: Yeah, I think there's some codes that you pick up
- 5:50Speaker 1: on people they don't realize, you know. But yeah, no,
- 5:53Speaker 1: I think that's interesting. Just people that are able to
- 5:56Speaker 1: examine that, like how people operate and how we perceive
- 5:59Speaker 1: certain things. And you're a guy that's kind of like,
- 6:03Speaker 1: I guess the way you've operated has kind of changed
- 6:06Speaker 1: over the past few years. Maybe I know it's certainly
- 6:09Speaker 1: like grown in perception, like your ability to reach people
- 6:12Speaker 1: has grown.
- 6:12Speaker 2: Yes.
- 6:13Speaker 1: You are a physician scientist, is that correct? Yes. Okay,
- 6:17Speaker 1: and what exactly does that term mean?
- 6:18Speaker 2: That means I practice medicine. Okay. And, you know, I
- 6:23Speaker 2: see and examine patients every day, board certified in internal
- 6:27Speaker 2: medicine and cardiology by the National Board of Physicians and Surgeons.
- 6:31Speaker 1: So also a cardiologist.
- 6:32Speaker 2: And a cardiologist. But I'm also a scientist, meaning I
- 6:37Speaker 2: evaluate new concepts. I develop hypotheses. I use the scientific method.
- 6:49Speaker 2: And I, you know, conduct studies, case reviews, literature reviews,
- 6:57Speaker 2: analyze data, formulate an analysis, and then come up with opinions.
- 7:05Speaker 2: And through that method, I'm one of the most published
- 7:09Speaker 2: doctors in the world. And certainly the most published in
- 7:13Speaker 2: my field previously, which was heart and kidney disease. So
- 7:18Speaker 2: I came into the pandemic Locked and loaded. In 2007,
- 7:23Speaker 2: I had testified before the Congressional Oversight Panel for the FDA.
- 7:30Speaker 2: I had lectured at the European Medicine Association, New York
- 7:33Speaker 2: Academy of Sciences, lectured widely at virtually every major medical
- 7:38Speaker 2: school in the United States, published seminal papers. But when
- 7:42Speaker 2: the pandemic hit, what I saw within the first few
- 7:45Speaker 2: months is no one was going to to the problem.
- 7:51Speaker 2: No one was... You know when there's a fire or
- 7:55Speaker 2: a catastrophe, and let's say 9-11 and the building is burning,
- 8:02Speaker 2: most people ran this way. But some of these first responders,
- 8:06Speaker 2: they ran right into it. I found myself in the
- 8:10Speaker 2: same mode. First few weeks, I said, well, surely Harvard
- 8:13Speaker 2: will tell us what to do, or the Mayo Clinic, or...
- 8:19Speaker 2: Maybe the U.S.
- 8:20Speaker 1: Government.
- 8:20Speaker 2: Usually the government on medical things is a laggard. They're
- 8:26Speaker 2: not a leader. So if we had a new cancer problem,
- 8:31Speaker 2: we wouldn't say, well, what does the government say? The
- 8:35Speaker 2: government is behind academia.
- 8:39Speaker 1: Got it.
- 8:40Speaker 2: Within a few months of being into the pandemic, I said,
- 8:43Speaker 2: listen– You know, I need to do my part. I
- 8:47Speaker 2: know other doctors in the hospital are doing their part.
- 8:50Speaker 2: And I devised the first treatment protocol of how to
- 8:53Speaker 2: treat high-risk patients. We're talking elderly patients, patients with a
- 8:57Speaker 2: heart disease, lung disease, kidney disease at home with very
- 9:02Speaker 2: intensive therapies and oxygen at home to avoid too bad outcomes, hospitalization,
- 9:09Speaker 2: and death. And that became copyrighted as the McCullough Protocol.
- 9:12Speaker 2: It was published in the American Journal of Medicine in 2020. Immediately,
- 9:16Speaker 2: I was called before the U.S. Senate. I appeared November 19, 2020.
- 9:21Speaker 2: And so, the Association of American Physicians and Surgeons, a
- 9:27Speaker 2: leading doctor's group, did pick up the McCullough Protocol. It
- 9:30Speaker 2: became standard of care. And the principal's It became standard
- 9:36Speaker 2: of care when? Because it was- No, it became early
- 9:38Speaker 2: standard of care in 2020 for high-risk patients. We immediately
- 9:41Speaker 2: organized telemedicine units. And it was the McCullough Protocol that
- 9:46Speaker 2: kept the hospitalizations down. Remember, there were projections that we
- 9:50Speaker 2: were going to overrun our hospitals.
- 9:51Speaker 1: Oh, yeah. There were like emailing people like, do you
- 9:53Speaker 1: have a place we can put bodies at your house
- 9:54Speaker 1: or whatever?
- 9:55Speaker 2: I had patients in their 90s with pacemakers and heart failure.
- 9:59Speaker 2: And we got going early with the McCullough Protocol. We
- 10:01Speaker 2: start with getting fresh air, nasal sprays and gargles, nutraceuticals.
- 10:07Speaker 2: They all played small roles. Initially, the first year we
- 10:10Speaker 2: used hydroxychloroquine as our antiviral and antibiotics and other drugs.
- 10:14Speaker 2: Second year, ivermectin. And then third year, we actually used
- 10:17Speaker 2: Paxlovid came in the third year, molnupiravir. We used those drugs.
- 10:21Speaker 2: But I have to tell you, the winner was ivermectin,
- 10:23Speaker 2: for sure, for sure. But I think corticosteroids, prednisone played
- 10:27Speaker 2: a huge role. Anti-inflammatory drug called colchicine we use widely today.
- 10:35Speaker 2: And then antithrombotics.
- 10:37Speaker 1: What was the McCullough Protocol? What went into it? What
- 10:41Speaker 1: were you basically advocating for people?
- 10:43Speaker 2: I was saying that if we got behind on this illness,
- 10:49Speaker 2: it was becoming clear we can't start treating when people
- 10:53Speaker 2: are sick enough to go in the hospital. Virtually every
- 10:56Speaker 2: death occurred in the hospital. So McCullough Protocol said there's
- 10:59Speaker 2: two bad outcomes, hospitalization and death. And if we can
- 11:04Speaker 2: Treat up front and never go in the hospital. We'll
- 11:06Speaker 2: get through the illness. Now, I did an artificial intelligence
- 11:09Speaker 2: search recently, which is a great use of AI. And
- 11:12Speaker 2: I asked AI, tell me what percent of the world's
- 11:16Speaker 2: population contracted COVID? And it searched every single database and
- 11:21Speaker 2: what have you. And, you know, the number it came
- 11:23Speaker 2: up with was 90%. Wow. Now, the pre-programmed bias that's
- 11:29Speaker 2: still left in AI– is promotional of pandemic fear, which
- 11:37Speaker 2: you're still at risk, promoting vaccines, and doing everything it
- 11:44Speaker 2: can to tell people they have no other options.
- 11:47Speaker 1: Right.
- 11:47Speaker 2: It's pre-programmed. So if you go to Grok— Is that true?
- 11:50Speaker 2: It's true. Let me give you an example.
- 11:52Speaker 1: Okay.
- 11:52Speaker 2: If you go to Grok and you say, who's Dr.
- 11:54Speaker 2: Peter McCullough? It'll say, well, Dr. McCullough is a cardiologist,
- 11:59Speaker 2: and it'll go on and on. It'll say, but he's
- 12:02Speaker 2: a conspiracy theorist, and he lost his board certifications. It'll
- 12:06Speaker 2: start saying all these things. I said, listen, just say
- 12:09Speaker 2: who it is. Don't put in any defamatory comments. Just
- 12:13Speaker 2: give the straight facts. Then it'll actually give a straight answer.
- 12:17Speaker 2: So Grok will tell you, I'm the most published person
- 12:20Speaker 2: on the pandemic, period, in the world. And so if
- 12:23Speaker 2: you actually tell Grok, stop all the BS, it'll do it.
- 12:27Speaker 2: With Alter AI, you don't have to do that. So
- 12:30Speaker 2: at McCullough Foundation, I started a foundation. We formed a
- 12:33Speaker 2: relationship with Alter AI, and we pay for it, and
- 12:38Speaker 2: we get a clean feed. But I think even Copilot
- 12:41Speaker 2: will come up with– Yeah, formerly practicing. No, I'm in practice.
- 12:45Speaker 2: I just saw patients yesterday. I mean, look, it just
- 12:48Speaker 2: goes on and on.
- 12:49Speaker 1: Dr. Peter McCullough, yeah, formerly practicing as a cardiologist and internist.
- 12:55Speaker 2: Wrong, because I'm practicing today.
- 12:57Speaker 1: He has highly published in medical literature, over 1,000 publications,
- 13:00Speaker 1: cited tens of thousands of times, became widely known during
- 13:02Speaker 1: the COVID-19 pandemic for his early advocacy of outpatient treatment protocols,
- 13:08Speaker 1: including controversial early use approaches and for his strong public
- 13:12Speaker 1: criticisms of COVID-19 vaccines. Yeah. Okay.
- 13:17Speaker 2: Well, it's getting there. You know, the thing about artificial intelligence,
- 13:21Speaker 2: which I think is a huge advance. By the way,
- 13:23Speaker 2: I'm using it in my practice every day now. Huge advance.
- 13:27Speaker 1: One more thing here. His views on COVID-19 vaccines and
- 13:29Speaker 1: related topics have been heavily criticized by mainstream medical organizations, fact-checkers,
- 13:33Speaker 1: and sources like factcheck.org, which describe many of his claims
- 13:37Speaker 1: as misinformation or unsupported.
- 13:40Speaker 2: Do you know not a single medical organization has reached
- 13:43Speaker 2: out to me even for a discussion? And, you know, factcheck.org,
- 13:49Speaker 2: that's not a medical organization.
- 13:50Speaker 1: No idea what that is.
- 13:52Speaker 2: So the idea is, let's say a medical organization said,
- 13:56Speaker 2: let's have a discussion about COVID vaccine complications. Not a
- 14:01Speaker 2: single one. There hasn't been a single medical school in
- 14:05Speaker 2: the United States that's even had a Grand Rounds on this,
- 14:08Speaker 2: let alone invite me to present Grand Rounds.
- 14:10Speaker 1: Why do you think that is, that they haven't reached
- 14:13Speaker 1: out to you to have a conversation?
- 14:15Speaker 2: They haven't reached out to anybody.
- 14:17Speaker 1: Okay.
- 14:17Speaker 2: There is a tremendous willful blindness to what's gone on
- 14:25Speaker 2: through the pandemic. There has been no review of lessons learned.
- 14:31Speaker 2: What did we learn from the pandemic?
- 14:33Speaker 1: I agree. It's so wild. So much information was every day.
- 14:36Speaker 1: It was this, this, go here, get a booster. If
- 14:38Speaker 1: you can't like get a vaccine, like hang your family
- 14:41Speaker 1: member out of a window, we'll have an archer come
- 14:43Speaker 1: by with a vaccine like from Pfizer. Yeah, we can,
- 14:46Speaker 1: you know, we'll vaccine them from the road or whatever.
- 14:48Speaker 1: It's like it was getting crazy. But yeah, it's kind
- 14:50Speaker 1: of wild how afterwards there hasn't been as much like, hey,
- 14:54Speaker 1: these are the things we learned. This is like what
- 14:56Speaker 1: we've learned as a society.
- 14:57Speaker 2: Well, we're told over and over again, there's going to
- 15:00Speaker 2: be another one. It's called Disease X. It's going to
- 15:04Speaker 2: come out of another bio lab.
- 15:06Speaker 1: Shit, it's going to come out of Miami, I'll tell
- 15:08Speaker 1: you that.
- 15:10Speaker 2: Or Galveston, Texas. They got a BSL-4 lab there.
- 15:13Speaker 1: Do they? I don't know. They got some BBLs over
- 15:16Speaker 1: in Miami.
- 15:16Speaker 2: No, I know that.
- 15:17Speaker 3: Is it really?
- 15:18Speaker 2: They're dealing with some bad stuff down there.
- 15:20Speaker 1: Okay. Mark that. I want to go back and talk
- 15:21Speaker 1: about that in a second. Wait, so this is it
- 15:23Speaker 1: right here, defining Disease X.
- 15:25Speaker 2: Disease X. Well, look at Bloomberg School of Public Health.
- 15:27Speaker 2: Who's the major funder of Bloomberg School of Public Health?
- 15:30Speaker 2: Bill Gates. Bill Gates. This is a dream. This is
- 15:34Speaker 2: a dream of those who want to vaccinate the world
- 15:37Speaker 2: is they want another disease X.
- 15:40Speaker 1: Of course. It's another industrial war complex. That's what this is.
- 15:42Speaker 2: Well, you got it.
- 15:43Speaker 1: But it's on your bodies. I do want to say this.
- 15:45Speaker 1: And Bill might just be trying to solve whatever he
- 15:47Speaker 1: was potentially giving his wife. I don't know. That's allegedly.
- 15:50Speaker 1: But I will say this. I want to read this
- 15:52Speaker 1: right here because you mentioned disease X. I haven't heard
- 15:54Speaker 1: about it. Since 2018, the mysterious and often misrepresented hypothetical
- 15:58Speaker 1: pathogen has been at the heart of international pandemic preparedness efforts.
- 16:03Speaker 1: Just that sentence alone, when you look at that sentence,
- 16:06Speaker 1: look how front-loaded and vague it is. Since 2018, this mysterious,
- 16:13Speaker 1: often misrepresented hypothetical pathogen has been at the heart of
- 16:18Speaker 1: international pandemic preparedness efforts. Like, we're so prepared. for we
- 16:22Speaker 1: don't even, for something that's super vague. It's just like
- 16:25Speaker 1: you can feel it setting you up for something.
- 16:27Speaker 2: Well, let's go to CEPI, the Coalition for Epidemic Preparedness
- 16:32Speaker 2: and Innovation. It's founded in 2017 by the World Economic
- 16:36Speaker 2: Forum and Bill Gates. And CEPI, in its business plan
- 16:42Speaker 2: in 2017, says there's going to be a series of
- 16:46Speaker 2: these pandemics, one after another, coming in like hurricanes. And
- 16:50Speaker 2: for each one, there'll be only one solution, mass vaccination.
- 16:55Speaker 2: And CEPI is a vaccine incubator. They're going to be ready.
- 16:59Speaker 2: Let me tell you, vaccines in pandemics is big business,
- 17:05Speaker 2: way more than pro sports, way more than anything else
- 17:08Speaker 2: you can think of. It's huge business. And in this
- 17:11Speaker 2: world of, we don't hear about other forms in this
- 17:16Speaker 2: industrial complex now, other things now outside of Biological threats
- 17:22Speaker 2: and then countermeasures, which is a military term, which are vaccines, therapeutics,
- 17:26Speaker 2: and protective equipment. But the idea is these are so
- 17:30Speaker 2: richly funded. They're so richly funded that the entity that
- 17:35Speaker 2: holds the threat and holds the antidote, they hold power.
- 17:39Speaker 2: Can you imagine the negotiating power you would have if
- 17:42Speaker 2: you said, hey, listen, I got COVID-20 locked and loaded
- 17:46Speaker 2: right now in an undisclosed location. can get the whole
- 17:50Speaker 2: country sick. We want a little better tariff situation. Can
- 17:55Speaker 2: you imagine the negotiating power? And Peter Daszak, who's part
- 18:00Speaker 2: of this whole conspiracy to create SARS-CoV-2, when he testified
- 18:05Speaker 2: in the House of Representatives, he said, I left a
- 18:08Speaker 2: whole bunch of samples back in Wuhan.
- 18:11Speaker 1: I'm confused. What was he doing there?
- 18:13Speaker 2: Peter Daszak was the go-between between Dr. Ralph Baric at
- 18:18Speaker 2: University of North Carolina, Chapel Hill, who devised the virus
- 18:21Speaker 2: and was publishing on it, and the federal government. Dasik
- 18:25Speaker 2: was at the EcoHealth Alliance. It's a go-between organization that
- 18:28Speaker 2: was shuttling money for barracks projects over to Wuhan. Dasik
- 18:33Speaker 2: had been to Wuhan many, many times. He knew that
- 18:36Speaker 2: lab well.
- 18:36Speaker 1: To create the virus, you mean?
- 18:38Speaker 2: Correct.
- 18:39Speaker 1: Understood. Okay, let's back up one second. I just want
- 18:41Speaker 1: to look at CEPI. Who created CEPI? Bring that back up.
- 18:44Speaker 2: CEPI was a World Economic Forum organization and the Gates Foundation.
- 18:47Speaker 2: You'll find, I think the government of Germany and India,
- 18:50Speaker 2: I believe was involved as well. But this is a
- 18:53Speaker 2: richly funded multi-billion dollar organization. You just can't imagine how
- 18:58Speaker 2: big these, Oh, I.
- 18:59Speaker 1: Can totally, you know, you look at the industrial war
- 19:01Speaker 1: complex and now you start to see it's the industrial
- 19:05Speaker 1: medical complex, right? That's the new one that really seems
- 19:07Speaker 1: like it's sprouted over the past 20 years.
- 19:09Speaker 2: Correct.
- 19:09Speaker 1: Right here. CEPI is the Coalition for Epidemic Preparedness Innovations,
- 19:12Speaker 1: a global organization focused on accelerating vaccine.
- 19:16Speaker 2: Vaccine development.
- 19:17Speaker 1: Okay. Sorry. It was created in 2017 through a partnership
- 19:20Speaker 1: between the governments of Norway and India, the Wellcome Trust
- 19:24Speaker 1: and the Bill and Melinda Gates Foundation.
- 19:26Speaker 2: Yep.
- 19:29Speaker 1: And go back to disease X. I want to just
- 19:31Speaker 1: read what it was really quick.
- 19:35Speaker 2: By the way, CEPI's got a big disease X section.
- 19:37Speaker 2: They have a whole white paper on it. Wow.
- 19:40Speaker 1: Disease X is a placeholder concept that refers to a
- 19:43Speaker 1: pandemic pathogen that has not yet been characterized. How vague
- 19:47Speaker 1: is that? Like, hey, it exists. but we don't know
- 19:50Speaker 1: what it is exactly yet.
- 19:52Speaker 2: But we have a vaccine for it.
- 19:54Speaker 1: Its purpose is to encourage proactive thinking about pathogens that
- 19:57Speaker 1: could cause a pandemic. Oh, so disease X isn't an
- 20:01Speaker 1: actual disease. It's a plan.
- 20:03Speaker 2: It's a plan for a disease. So disease X is.
- 20:09Speaker 2: was SARS-CoV-2. It was a planned disease.
- 20:13Speaker 1: Got it.
- 20:14Speaker 2: And here we are. It was a plan. And, you know,
- 20:18Speaker 2: in my first book, Courage to Face COVID-19, we expose
- 20:22Speaker 2: CEPI and what we call a biopharmaceutical complex. You called
- 20:26Speaker 2: it a bioindustrial complex. Same thing. But there has been
- 20:30Speaker 2: a cartel that's formed. It's very powerful. And it's probably
- 20:37Speaker 2: back 2004 is probably when it started with the BioShield Act.
- 20:42Speaker 2: But it includes the World Health Organization, the World Economic Forum,
- 20:45Speaker 2: Gates Foundation, Wellcome Trust, the Rockefeller Foundation, CEPI, Gavi, Unitate,
- 20:53Speaker 2: all these organizations, all organized to essentially plan for, create pandemics,
- 21:03Speaker 2: and then respond to them. And that's how... COVID-19 ultimately,
- 21:10Speaker 2: it's essentially known now. This was not a spontaneous thing
- 21:13Speaker 2: from nature. This was planned.
- 21:16Speaker 1: Which is the number one piece of evidence that makes
- 21:17Speaker 1: you feel like it's known, that it was planned?
- 21:20Speaker 2: Well, I think the best source of all of the
- 21:22Speaker 2: evidence is Peter Bregan's book, COVID-19 and the Global Predators,
- 21:26Speaker 2: We Are the Prey. I wrote the introduction for it.
- 21:29Speaker 2: But he goes back again to about 2004, the Bioshield Act,
- 21:35Speaker 2: where he outlines 36 different pandemic preparedness planning events. 36, historically.
- 21:42Speaker 2: He's got a wonderful timeline. And of those, two dozen
- 21:48Speaker 2: provide written documents. You can just read them, including one
- 21:51Speaker 2: of them's the Prep Act in 2005, which says there
- 21:54Speaker 2: will be a pandemic and we will have one. 2005,
- 21:57Speaker 2: that was a Bush administration, HHS said, listen, we're going
- 22:01Speaker 2: to have one. And when we do, we're going to
- 22:05Speaker 2: have countermeasures. And when we roll out these countermeasures, you
- 22:08Speaker 2: better take one, and there is a complete freedom of liability.
- 22:13Speaker 2: But 24 of them provide written evidence, and then six
- 22:17Speaker 2: of them are filmed. You could just go watch them.
- 22:20Speaker 2: So is he kind of a whistleblower, do you feel like?
- 22:21Speaker 2: He was a whistleblower back in the days where essentially
- 22:26Speaker 2: Prozac wiped out consultative counseling psychiatry. Overnight, he wrote the
- 22:33Speaker 2: book Talking Back to Prozac.
- 22:36Speaker 1: New year, new routines. But have you ever stopped to
- 22:40Speaker 1: think about what your shower water is doing to your
- 22:44Speaker 1: skin and hair? Have you? Most people spend thousands every
- 22:49Speaker 1: year on skin care and hair care and hair, hair, skin, skin, care, hair.
- 22:54Speaker 1: Trying to fix dryness, breakouts, and dull hair. Dull hair!
- 23:00Speaker 1: Without realizing the real problem starts before the products even
- 23:03Speaker 1: go on. It's the quality of your shower water. And
- 23:07Speaker 1: that's where Jolie comes in. Jolie is a beauty wellness
- 23:12Speaker 1: company with a clinically proven filtered shower head designed to
- 23:16Speaker 1: remove chlorine and heavy metals that can damage your skin
- 23:20Speaker 1: and damage your hair. It installs in minutes, fits all showers,
- 23:25Speaker 1: looks great, and delivers amazing pressure. And right now, it
- 23:29Speaker 1: starts at just $ 98. So head on over to joelieskinco.com
- 23:34Speaker 1: slash Theo to get yours. That's J-O-L-I-E-S-K-I-N-C-O dot com slash Theo.
- 23:44Speaker 1: And if you or your loved one doesn't love it,
- 23:46Speaker 1: you can return it for a full refund within 60 days,
- 23:51Speaker 1: no questions asked. Also available on Amazon. Start the year
- 23:55Speaker 1: with better water. Get Jolie for $ 98 today. Hate to
- 24:00Speaker 1: break the news to you, but it's March. And that's
- 24:04Speaker 1: when things get real. You're not resetting anymore. You're either
- 24:08Speaker 1: building momentum or watching the year slide by. This is
- 24:13Speaker 1: the month where ideas either fade or turn into something legit.
- 24:18Speaker 1: If you're selling stuff, growing something, or trying to make
- 24:21Speaker 1: this thing actually work. Shopify helps keep you moving without
- 24:26Speaker 1: feeling like you're drowning. Marketing, inventory, checkout, growth, it's all
- 24:31Speaker 1: in one place. So you're not duct taping your business
- 24:34Speaker 1: together at 2 a.m. Momentum is everything. If you've been
- 24:39Speaker 1: thinking about betting on yourself, Shopify is the move. Shopify
- 24:43Speaker 1: also lets you sell directly on socials, YouTube, TikTok, Instagram,
- 24:48Speaker 1: and Facebook. It might be time to invest in your
- 24:50Speaker 1: idea for once, not somebody else's. If you've been thinking
- 24:54Speaker 1: about starting something, go to shopify.com slash Theo and see
- 24:59Speaker 1: what it feels like to actually be in control of
- 25:02Speaker 1: your own thing. That's shopify.com slash Theo.
- 25:07Speaker 2: But COVID-19 and the global virus, it has the best timeline. Now,
- 25:11Speaker 2: Robert F. Kennedy wrote a book about the real Anthony Fauci.
- 25:13Speaker 2: He's got a timeline in it too. Our book, Courage
- 25:16Speaker 2: to Face COVID-19, I think outlines who this complex is
- 25:22Speaker 2: and what they're doing.
- 25:24Speaker 1: This medical industrial complex. Yes, yes. Yeah, who is it exactly?
- 25:27Speaker 2: Yeah, but hang on. People have said, well, wait a minute,
- 25:30Speaker 2: it's big pharma. I disagree. I think the pharmaceutical companies
- 25:34Speaker 2: and the in vitro diagnostic companies and the gown and
- 25:37Speaker 2: mask companies They're suppliers to the complex. The complex is
- 25:44Speaker 2: this organized group that in many ways they have bad intentions.
- 25:53Speaker 2: And look at the last World Economic Forum meeting. They
- 25:58Speaker 2: play a big role in this. It was one of
- 26:00Speaker 2: the speeches where they said, you know, COVID-19 pandemic was
- 26:04Speaker 2: a test of human compliance. They just come out and
- 26:07Speaker 2: say that.
- 26:09Speaker 1: Was it just written or did someone speak to that?
- 26:11Speaker 2: Someone say it. Yeah, let's pull it up. World Economic Forum,
- 26:15Speaker 2: the pandemic was a test of human compliance. But the
- 26:19Speaker 2: point I'm making is that there's a lot of interest
- 26:27Speaker 2: in this whole field. We have divisions. Here we go.
- 26:33Speaker 2: Who said that?
- 26:34Speaker 1: No, the World Economic Forum did not describe the pandemic
- 26:36Speaker 1: as a test of human compliance. test of social responsibility
- 26:40Speaker 1: key details from that and related WF publications include test
- 26:44Speaker 1: of social responsibility article explicitly stated that COVID-19 was the
- 26:47Speaker 1: test of social responsibility.
- 26:49Speaker 2: Citing the fact that people worldwide complied with the unimaginable restrictions.
- 26:54Speaker 1: Well pretty close oh I don't doubt that it felt
- 26:58Speaker 1: certainly like a psychological experiment I mean one of the
- 27:01Speaker 1: things I was going to ask you is what do
- 27:02Speaker 1: you feel like they learned from this like what valuable
- 27:05Speaker 1: information was taken away like whoever these powers are that
- 27:08Speaker 1: be you know.
- 27:09Speaker 2: Well, I hope that they learned that when they have
- 27:14Speaker 2: a vaccine that's an epic failure, that that's permanently going
- 27:20Speaker 2: to set back aspirations for future worldwide vaccination. Now, if
- 27:25Speaker 2: this vaccine would have worked and everyone took it and
- 27:29Speaker 2: COVID magically went away and just everything cleared up in
- 27:32Speaker 2: a month or two and nobody was sick anymore and
- 27:35Speaker 2: there was no side effects, these guys would have been heroes.
- 27:39Speaker 1: Right?
- 27:40Speaker 2: Remember Bill Gates comes out in April of 2020 and says,
- 27:45Speaker 2: this pandemic doesn't end until virtually every person in the
- 27:50Speaker 2: world takes a vaccine. How does he know? It's April
- 27:55Speaker 2: of 2020. Vaccines.
- 27:58Speaker 1: Right. Who knows what's going to happen? Right. Yeah. If
- 28:01Speaker 1: you have a strategy, then of course that's what you're
- 28:02Speaker 1: going to say.
- 28:03Speaker 2: Well, Gates Foundation and the Bloomberg School of Public Health
- 28:07Speaker 2: in 2017 announced Hold a planning seminar. It's called the
- 28:11Speaker 2: SPARS pandemic. S-P-A-R-S pandemic. It's at Johns Hopkins. And it
- 28:18Speaker 2: says there's going to be a coronavirus pandemic in 2017.
- 28:22Speaker 2: I remember reading that. They held it in 2017. They
- 28:25Speaker 2: thought it was going to hit in 2025.
- 28:28Speaker 1: Okay.
- 28:28Speaker 2: It hits in late 2019. Then, and this is one
- 28:33Speaker 2: of the ones that is well documented as a planning event,
- 28:36Speaker 2: and then event 201. Come on. That's November of 2019.
- 28:40Speaker 2: What is Event 201? Event 201 was, again, Johns Hopkins
- 28:44Speaker 2: Bloomberg School of Public Health, Gates Foundation. They have a meeting.
- 28:48Speaker 2: They said, we are really going to have a coronavirus pandemic.
- 28:52Speaker 2: They bring over George Gao, who's the Chinese CDC director,
- 28:57Speaker 2: and he's paired up with others there. Averill Haynes is there.
- 29:00Speaker 2: Who's Averill Haynes? She's a former World Economic Forum associate,
- 29:05Speaker 2: becomes our director of national intelligence under Biden.
- 29:09Speaker 1: Really?
- 29:10Speaker 2: And she's with George Gao and they're saying, oh, we're
- 29:13Speaker 2: going to have a COVID pandemic. And this is how
- 29:15Speaker 2: it's essentially, it's going to be used to railroad mass
- 29:19Speaker 2: vaccination on the world.
- 29:20Speaker 1: But do you believe that everybody knew that? Or do
- 29:22Speaker 1: you believe that a select group knew it? And then
- 29:24Speaker 1: they just, because say if I have a devious plan, right?
- 29:28Speaker 1: I could still go to someone and say, hey, this
- 29:30Speaker 1: is what's happening. I don't have to say I'm the
- 29:32Speaker 1: one who's causing what's happening, right? So were there, because
- 29:35Speaker 1: the tough part is when you start to think of
- 29:37Speaker 1: like that everybody was complicit, like, you know what I'm saying?
- 29:41Speaker 1: That's the part that starts to feel very impossible to
- 29:45Speaker 1: a lot of people.
- 29:45Speaker 2: I don't think that's the case. I got to tell you,
- 29:47Speaker 2: I was in practice then. I had no idea this
- 29:49Speaker 2: was going on. Everybody I talked to at my institutions
- 29:52Speaker 2: all over the whole country, all over Europe, no one
- 29:55Speaker 2: knew this was happening. The point is this was going
- 29:58Speaker 2: on This was in the open.
- 30:00Speaker 1: Got it.
- 30:01Speaker 2: No one was paying attention. I bet, I bet no
- 30:04Speaker 2: one briefed Trump that in 2017 that they're going to,
- 30:11Speaker 2: you know, they were planning for a coronavirus pandemic. I
- 30:15Speaker 2: bet there wasn't a briefing.
- 30:16Speaker 1: But does it also make sense that as our world
- 30:18Speaker 1: evolves and as like biohacking and like research and everything
- 30:22Speaker 1: becomes so much more intense and like medicine is evolving
- 30:25Speaker 1: all the time and science is evolving constantly. That's just
- 30:28Speaker 1: what it does. That there would be, it would make
- 30:32Speaker 1: some sense to strategize that something like this could happen.
- 30:35Speaker 1: Like that maybe we've moved on from like actual, like,
- 30:40Speaker 1: like huge wars on land. And then it's going to
- 30:42Speaker 1: become more like, yeah, I remember years ago you would
- 30:44Speaker 1: hear like, oh, the next war is going to be
- 30:46Speaker 1: in the water or it's going to be in the air, right?
- 30:48Speaker 1: It's going to be a virus. You would hear stuff
- 30:50Speaker 1: like that a lot, like just kind of randomly.
- 30:52Speaker 2: Oh, there's movies, right? There's movie Contagion and all these
- 30:55Speaker 2: other movies. What experts will say in infectious disease and
- 31:00Speaker 2: vaccinology is that the reason why we have to have
- 31:03Speaker 2: biolabs is we have to get ahead of nature. So
- 31:08Speaker 2: nature sooner or later is going to throw us a
- 31:11Speaker 2: really bad bug, and we're susceptible to these. And the
- 31:15Speaker 2: case example they use is Spanish flu. In my book
- 31:18Speaker 2: on vaccines, we spend a lot of time on the
- 31:21Speaker 2: Spanish flu, which was very unique post-World War I. We
- 31:27Speaker 2: have young men in army barracks. And remember, influenza doesn't
- 31:32Speaker 2: directly kill people. What kills them is a secondary staphylococcal pneumonia,
- 31:37Speaker 2: and that's what they die of. The point that was made, though,
- 31:41Speaker 2: is that, listen, we could have another Spanish flu. And
- 31:44Speaker 2: when COVID-19 pandemic broke, don't forget, the storyline we were
- 31:50Speaker 2: told is, oh, here we go again. It's another Spanish flu. Now, remember,
- 31:55Speaker 2: Anthony Fauci said, knows it came out of the lab,
- 31:59Speaker 2: but they collaborate together to say, you know what, it
- 32:02Speaker 2: came out of a fish market. In fact, the WHO,
- 32:08Speaker 2: when it was asked to investigate early in 2020, where
- 32:11Speaker 2: did this virus come from? Rear Admiral Brett Gerard, someone
- 32:16Speaker 2: who went to my medical school in Dallas at Southwestern,
- 32:19Speaker 2: he was on President Trump's first task force, Brett Gerard
- 32:24Speaker 2: nominates three U.S. scientists to go to Wuhan. The WHO says, no, no,
- 32:30Speaker 2: we don't want them. We want Peter Daszak. Isn't that interesting? Daszak,
- 32:36Speaker 2: who knew, in fact, he was shuttling the plans over there.
- 32:39Speaker 2: So Daszak goes over to Wuhan and he looks around.
- 32:43Speaker 2: He goes, I don't know where this virus came from,
- 32:47Speaker 2: but it definitely didn't come out of the lab. He
- 32:50Speaker 2: had been to the lab dozens of times. He shuttled
- 32:53Speaker 2: the plans over. Anthony Fauci was well aware of this.
- 32:56Speaker 2: They started covering up their emails. Rand Paul's got a
- 32:59Speaker 2: great book called Deception. He has every single one of
- 33:03Speaker 2: these events in it. But the point I'm making is
- 33:08Speaker 2: those in this field keep saying, listen, there could be
- 33:11Speaker 2: another Spanish flu. We must get ahead of this. However,
- 33:15Speaker 2: with the 2004 BioShield Act and the 2005 PrEP Act,
- 33:21Speaker 2: the governments got in the game of bioterrorism.
- 33:25Speaker 1: How did those acts allow them to do that?
- 33:28Speaker 2: Well, what happened was we had the anthrax scare, which
- 33:35Speaker 2: largely looks like it was a deranged government worker at
- 33:41Speaker 2: Fort Detrick who was working on the anthrax vaccine for
- 33:45Speaker 2: the military. And There has been lost enthusiasm for this
- 33:49Speaker 2: vaccine based on safety. And so he actually sent some
- 33:52Speaker 2: letters to Leahy and other people in Congress. Some people
- 33:56Speaker 2: got sick. To this day, not a single soldier has
- 34:00Speaker 2: died of anthrax because an enemy shot an anthrax capsule
- 34:03Speaker 2: the other way. It's all been, you know, this event.
- 34:08Speaker 1: Like these social events.
- 34:09Speaker 2: Yeah, social events.
- 34:12Speaker 1: Yeah, what happened with anthrax?
- 34:14Speaker 2: Well, there's another great book with– there you go.
- 34:19Speaker 1: Letters containing anthrax spores were mailed to several news media
- 34:22Speaker 1: offices and the senators, Tom.
- 34:23Speaker 2: Daschle and Patrick Leahy.
- 34:25Speaker 1: Patrick Leahy killing five people.
- 34:27Speaker 2: And infecting 17. But what I'm saying is the anthrax
- 34:29Speaker 2: scare and SARS-1, the SARS-1 outbreak, led to this idea
- 34:35Speaker 2: that– wait a minute.
- 34:37Speaker 1: There's money here.
- 34:39Speaker 2: First off, this could really happen. So we should be prepared.
- 34:44Speaker 2: That's the reason why it's called the Prep Act. We
- 34:46Speaker 2: should be prepared and our governments should get in this game.
- 34:50Speaker 2: So the military got in the game with a unit
- 34:53Speaker 2: called DARPA, D-A-R-P-A. And the National Institutes of Health got
- 34:58Speaker 2: in this game with a unit called BARDA, B-A-R-D-A. And
- 35:02Speaker 2: these are pandemic preparedness units. Well, as they churned over time,
- 35:08Speaker 2: There's funding of biolabs, and let's see how we can
- 35:11Speaker 2: make this organism more contagious. And would this work? And
- 35:14Speaker 2: let's test it here. And they got to Barak. Barak
- 35:17Speaker 2: got to the point of, well, let's take a human coronavirus,
- 35:20Speaker 2: of which there's four that we can get as a
- 35:22Speaker 2: common cold, and let's take the spike protein, the surface
- 35:25Speaker 2: of it, from a bat, and then start to play
- 35:31Speaker 2: with this until it can lock in with a human
- 35:34Speaker 2: receptor called the ACE2 receptor and invade humanized epithelial cells
- 35:40Speaker 2: in animals. And when they did that in Wuhan, it
- 35:44Speaker 2: basically killed the animals. They said, ooh, now we've got
- 35:48Speaker 2: a real, we took something benign, which is a coronavirus,
- 35:52Speaker 2: and we've made it potentially lethal. Now in those papers,
- 35:56Speaker 2: 2015- In what papers? In pre-reviewed papers, 2015, Nature Communications
- 36:03Speaker 2: in 2016, in the proceedings of the National Academy of Science,
- 36:07Speaker 2: the first author- is Menachery, M-E-N-A-C-H-E-R-Y. Those two papers describe
- 36:16Speaker 2: primordial SARS-CoV-2. In 2015 and 2016, this is published. These
- 36:19Speaker 2: are high-level peer-reviewed journals. And the title of the paper
- 36:23Speaker 2: is A SARS-Like CoV, Coronavirus, WIV1, Wuhan Institute of Virology 1,
- 36:33Speaker 2: Virus Poised for Human Emergence. So here they are in
- 36:37Speaker 2: these papers, and you can pull them up, poised for
- 36:40Speaker 2: human emergence. So they were announcing to the world, this
- 36:44Speaker 2: isn't my field, I wasn't reading this.
- 36:46Speaker 1: But was this a good guy saying this, or was
- 36:47Speaker 1: this a bad guy saying this?
- 36:49Speaker 2: These are the guys who were working. This paper was done,
- 36:53Speaker 2: the work was done in the Wuhan Institute of Virology.
- 36:56Speaker 1: Okay.
- 36:57Speaker 2: They say it's gain-of-function research, but it was grandfathered in
- 37:01Speaker 2: because it was started before the Obama ban on this.
- 37:04Speaker 2: And we took it over to Wuhan. They thanked the
- 37:07Speaker 2: Chinese for their collaboration. Now, the second paper that came
- 37:11Speaker 2: out a month later in the Presidium of the National
- 37:13Speaker 2: Committee of Sciences, they actually put the Chinese authors on.
- 37:17Speaker 2: So this was in many ways in the infectious disease
- 37:21Speaker 2: community in the open. Now, this paper, by the way,
- 37:24Speaker 2: when the U.S. government funds work like this, they must
- 37:28Speaker 2: put the genetic code of the new virus they created
- 37:32Speaker 2: in a central data bank.
- 37:35Speaker 1: Did they do that? No.
- 37:37Speaker 2: And when Ralph Baric was interviewed on this in 2021,
- 37:40Speaker 2: they said, wait a minute, did you submit your genetic code?
- 37:44Speaker 2: Does the virus, does it match your code from here?
- 37:47Speaker 2: He says, well, I've had a discussion with the National
- 37:49Speaker 2: Institutes of Health and we believe it's a national security
- 37:52Speaker 2: issue and we are not going to release it. Now,
- 37:55Speaker 2: his virus didn't have in it a key part in
- 37:59Speaker 2: the spike protein called the furin cleavage joint. And it
- 38:02Speaker 2: looks like that was the final thing that was added later.
- 38:05Speaker 1: Understood. We hear about spike proteins a lot. What is that?
- 38:08Speaker 2: The spike protein is a spike or this projection on
- 38:13Speaker 2: the surface of the virus. The ball of the virus
- 38:15Speaker 2: is called the nucleocapsid. The red part shown there is
- 38:18Speaker 2: the spike protein.
- 38:19Speaker 1: Okay.
- 38:20Speaker 2: The ball itself is benign. That's not going to kill you.
- 38:24Speaker 2: All the lethality in SARS-CoV-2, what killed people, and some
- 38:28Speaker 2: people truly did die of this, was the spike protein.
- 38:31Speaker 2: The spike protein allows the virus to inject itself in
- 38:34Speaker 2: the body. We sacrifice the part of the spike protein
- 38:38Speaker 2: near the ball. The S2 is sacrificed and S1 goes
- 38:42Speaker 2: into the body. Now that's with the infection. The vaccines,
- 38:47Speaker 2: Pfizer and Moderna, are the genetic code for the full
- 38:50Speaker 2: spike protein. So you take one of those vaccines. Now
- 38:54Speaker 2: the genetic code is producing the full length spike protein
- 38:58Speaker 2: in the human body.
- 38:59Speaker 1: Was there a moment, do you think, when they planned
- 39:01Speaker 1: to unleash the virus or did it just naturally sort
- 39:04Speaker 1: of enter society? That's where I'm a little bit confused.
- 39:08Speaker 1: Was there like a day, like a D-Day of sorts
- 39:10Speaker 1: where it's like, okay, this is when we're going to
- 39:12Speaker 1: just unleash this virus into the world? Or do you
- 39:15Speaker 1: think it was unleashed on accident? What is your thoughts
- 39:17Speaker 1: on that?
- 39:19Speaker 2: I don't exactly know, but I have listened to many opinions.
- 39:23Speaker 2: And one opinion who I think is on target is
- 39:26Speaker 2: former CDC director Robert Redfield. He believes it... leaked out
- 39:30Speaker 2: by accident summer of 2019. Accident.
- 39:34Speaker 1: It just seems so— it feels like there would be so
- 39:36Speaker 1: much security around something like this.
- 39:39Speaker 2: No, no.
- 39:40Speaker 1: There are— But if everybody's keeping it.
- 39:41Speaker 2: A secret— Listen, we've published this on my sub-stack, Focal Points,
- 39:47Speaker 2: Nick Hulsher at McCullough Foundation. There's over 3,000 biolabs. Do
- 39:52Speaker 2: you know there have been hundreds and hundreds of leaks?
- 39:55Speaker 2: This one down in Galveston, there's been a ton of leaks.
- 39:58Speaker 1: In Galveston, Texas? Sure.
- 40:02Speaker 2: These labs require biosecurity level four, means you have to
- 40:06Speaker 2: wear a hazmat suit, and they use reverse ventilation, what
- 40:09Speaker 2: have you. All you need is a ventilation system going out,
- 40:13Speaker 2: someone spilling a test tube, someone not being careful. And
- 40:17Speaker 2: the Biden administration in 2024, in the summer of 2024,
- 40:20Speaker 2: published this legislation. And it's concerning pathogens of pandemic potential
- 40:28Speaker 2: that are dual purpose. It's very important.
- 40:31Speaker 1: I'm a little confused.
- 40:33Speaker 2: And what that means is we are in the business
- 40:37Speaker 2: of creating pathogens that can create pandemics, but they have
- 40:43Speaker 2: a dual purpose to get the world sick. And to
- 40:46Speaker 2: create vaccines.
- 40:48Speaker 1: I see what you're saying. So they're able to create
- 40:50Speaker 1: a pathogen now that can get you just sick enough,
- 40:53Speaker 1: you're saying?
- 40:54Speaker 2: Get the whole world sick. Now, that's kind of tricky
- 40:57Speaker 2: because— Let.
- 40:57Speaker 1: Me read this really fast. Sorry. There have been no
- 40:59Speaker 1: recent reports of community-wide leak or environmental breach from the
- 41:02Speaker 1: biolabs in Galveston as early as 2026.
- 41:04Speaker 2: A lot.
- 41:07Speaker 1: In February 2025, reports disclosed that there were three incidents
- 41:11Speaker 1: in 2024 where researchers were potentially exposed to infectious agents
- 41:14Speaker 1: within the high containment labs. The Chapparavirus, a lab worker
- 41:21Speaker 1: accidentally punched their finger with a needle while handling an
- 41:23Speaker 1: infected guinea pig. Shout out, guinea pigs, all of them.
- 41:27Speaker 1: Chappar is a rare deadly hemorrhagic fever virus. Anthrax were
- 41:31Speaker 1: also cited in the annual biosafety summer release. and containment status.
- 41:35Speaker 1: In all three cases, the incidents were contained inside the lab.
- 41:38Speaker 2: So let's go to thefocalpoints.com. We're going to have to
- 41:41Speaker 2: start going to the original papers because you're getting snowed
- 41:44Speaker 2: on artificial intelligence. You're getting snowed. Okay, now do the
- 41:49Speaker 2: search button up there and type in biolab leak.
- 41:55Speaker 1: Galveston?
- 41:56Speaker 2: No, it'll come up. Okay. Let's pick any one of those.
- 41:59Speaker 2: Just pick the UNC Chapel Hill.
- 42:02Speaker 1: That's it right there?
- 42:05Speaker 2: Click on the link right there. And this is what
- 42:10Speaker 2: I do. I just go from the original papers and
- 42:13Speaker 2: none of this, I think.
- 42:15Speaker 1: Yeah, because a lot of AIs, that was Gemini, I think,
- 42:18Speaker 1: a lot of AIs, you just don't know what they're
- 42:19Speaker 1: pulling in. You're getting snowed.
- 42:20Speaker 2: The illusion of biosafety during SARS-CoV-2 research, multiple apparent occult
- 42:25Speaker 2: lab acquired infections identified under BSL-3 conditions, primary US labs.
- 42:30Speaker 2: And so, you know, we're starting to get the idea that,
- 42:33Speaker 2: That these labs are not infallible. And Trump has actually
- 42:38Speaker 2: stopped federal funding of these, but they're richly funded by
- 42:43Speaker 2: foundations like Gates Foundation, Rockefeller Trust, Wellcome Trust, and they're
- 42:47Speaker 2: big business for universities. Do you know that not a
- 42:51Speaker 2: single state has done an inventory of their biolabs? And
- 42:55Speaker 2: I'm on the Senate Committee for Arizona. And they asked, well, Doc,
- 42:59Speaker 2: what can we do to do better next time? I said,
- 43:01Speaker 2: why don't you do an inventory of what universities are
- 43:03Speaker 2: running bio labs?
- 43:05Speaker 1: Wow. So there's bio labs on college campuses right now.
- 43:07Speaker 2: Oh, for sure.
- 43:08Speaker 1: And are some of them handling pretty severely infectious diseases? Yes. Really? Yeah.
- 43:13Speaker 1: Go back to- Like which ones? Do you know?
- 43:15Speaker 2: Go back to focal points. And I want you to
- 43:17Speaker 2: pull up when I did. Search on this and do
- 43:22Speaker 2: pandemic potential dual. You're going to get the Biden- There
- 43:27Speaker 2: we go. Click on the top one. This is the government,
- 43:30Speaker 2: just scroll down. This is the government work on pandemics.
- 43:38Speaker 2: This is the Bioweapons Convention, 1975. It says we shouldn't
- 43:42Speaker 2: be in this business, so they call them biological threats.
- 43:45Speaker 2: And just go down. The Biden administration put out guidance
- 43:52Speaker 2: on this, of this dual-use potential. And it's a 31-page document.
- 44:00Speaker 2: and it's very minimal oversight. Listen, if you were making
- 44:05Speaker 2: a nuclear bomb in a university lab, you'd have the nuclear,
- 44:09Speaker 2: here it is, you'd have the Nuclear Regulatory Commission all
- 44:12Speaker 2: over you. And here, this is so light, voluntary reporting,
- 44:18Speaker 2: just kind of tell us what you're generally doing. You know,
- 44:22Speaker 2: there was a bio lab that someone found in Ridley, California.
- 44:26Speaker 2: There was one recently in Las Vegas. It's been said,
- 44:30Speaker 2: I can't back it up, but it's said they're all
- 44:33Speaker 2: over Ukraine. I am telling you, the next threat we
- 44:37Speaker 2: have is from a biolab. I feel pretty strongly about it.
- 44:40Speaker 1: Well, I think based on what's happened recently, yeah. I mean,
- 44:42Speaker 1: I think that would make a lot of sense to say.
- 44:45Speaker 1: You know, America feels super compromised, I feel like, in
- 44:48Speaker 1: a lot of, I know, shocking. And I think we
- 44:51Speaker 1: trusted the red, white, and blue, you know? You believe
- 44:54Speaker 1: that America was this thing for so long. And it
- 44:56Speaker 1: may have been at some point. But I feel like
- 44:59Speaker 1: the number one thing that I notice amongst a lot
- 45:01Speaker 1: of my friends is that people just feel that everyone's
- 45:04Speaker 1: questioning everything right now, that we don't trust. We don't
- 45:09Speaker 1: trust that our country, that our government, that the entities
- 45:13Speaker 1: out there are looking out for our best interest at all.
- 45:16Speaker 1: In fact, that they're using us as prey. What countries
- 45:20Speaker 1: do you feel like are leading the way in– in
- 45:25Speaker 1: fighting for like truth and transparency, do you feel like?
- 45:28Speaker 1: And then with that said, how hard would it be
- 45:31Speaker 1: for there to be this world like pandemic cabal to
- 45:35Speaker 1: take over?
- 45:36Speaker 2: Has the world ever agreed on anything?
- 45:39Speaker 1: No.
- 45:40Speaker 2: All 193 countries ever?
- 45:43Speaker 1: No.
- 45:44Speaker 2: Written language, religion, nothing. But suddenly this pandemic comes out
- 45:50Speaker 2: and all the countries agree? that essentially there's one solution,
- 45:56Speaker 2: mass vaccination. You've got genetic vaccines that have never been
- 46:02Speaker 2: used in mankind ever. And we're talking about largely messenger
- 46:07Speaker 2: RNA vaccines, Pfizer and Moderna, which are the leads.
- 46:10Speaker 1: So we'd never used genetic vaccines in the history of man?
- 46:14Speaker 2: Never. And so- Is that true?
- 46:17Speaker 1: Bring that up. These are the first genetic, what does
- 46:19Speaker 1: that mean exactly?
- 46:21Speaker 2: They're the first human messenger RNA vaccines. It's the genetic
- 46:26Speaker 2: code for the lethal spike protein. Got it. What a gamble.
- 46:32Speaker 2: So you have a protein that's been worked on for
- 46:35Speaker 2: years and years and years, and it's lethal. It's proven
- 46:39Speaker 2: to be lethal. Then we create the genetic code for
- 46:44Speaker 2: this lethal protein and inject the genetic code with no
- 46:49Speaker 2: idea what's going to shut it off.
- 46:51Speaker 1: No, genetic vaccines such as mRNA or DNA vaccines had
- 46:54Speaker 1: not been used in humans before 2020. They underwent preclinical
- 46:58Speaker 1: testing and early phase human clinical trials for conditions like influenza, rabies, Zika, HIV,
- 47:03Speaker 1: and cancer, but none received regulatory approval or widespread use
- 47:07Speaker 1: prior to the COVID-19 pandemic.
- 47:08Speaker 2: Wow. Now listen, messenger RNA has been around for a
- 47:11Speaker 2: long time. There's a paper by Lalani and colleagues, British
- 47:15Speaker 2: Medical Journal, that dates messenger RNA development back to about 1985.
- 47:21Speaker 2: Billions of dollars were poured into this by countries all over.
- 47:25Speaker 2: Big companies, CureVac, Sanofi, BioNTech came along, Moderna. And there's
- 47:33Speaker 2: a love affair with messenger RNA technology. I'm telling you,
- 47:36Speaker 2: love affair. Can you imagine any protein we want to,
- 47:40Speaker 2: we can make the code for, inject it and start
- 47:42Speaker 2: making a protein? The enthusiasm for messenger RNA is through
- 47:47Speaker 2: the roof. And when this pandemic came along, It was
- 47:53Speaker 2: like go time for those people in the messenger RNA world.
- 47:56Speaker 2: And it was a very important development step. And I
- 48:00Speaker 2: think it's very unfortunate no one briefed Trump on this. DARPA,
- 48:06Speaker 2: a research unit of the military. And this one you
- 48:08Speaker 2: have to bring up on the screen, guys.
- 48:09Speaker 1: And DARPA is basically our government's lab.
- 48:14Speaker 2: Yeah.
- 48:15Speaker 1: Okay.
- 48:16Speaker 2: Military.
- 48:17Speaker 1: Got it.
- 48:17Speaker 2: DARPA has a program in 2012– It's called the ADEPT
- 48:23Speaker 2: P3 program. They announced in 2012 that our aspiration is
- 48:29Speaker 2: to end pandemics within 60 days using messenger RNA vaccines
- 48:35Speaker 2: in 2012. See if you can bring up, yeah, click
- 48:38Speaker 2: on P3 right there. Click on that and scroll down
- 48:41Speaker 2: and you'll see.
- 48:42Speaker 1: A little- against any known or previously unknown infectious threat
- 48:52Speaker 1: within 60 days of identification of such a threat in
- 48:55Speaker 1: order to keep the outbreak from escalating and disruptions to
- 48:57Speaker 1: the military and homeland.
- 48:59Speaker 2: Now, click on that next link, Autonomous. Now, roll down.
- 49:02Speaker 2: There should be a figure. Is there a link there?
- 49:06Speaker 2: I guess not. But they literally show messenger RNA data.
- 49:12Speaker 2: in a little life cycle, that that's what they're using
- 49:15Speaker 2: in 2012. Lalani points out that this has been going
- 49:19Speaker 2: on for the longest time. It's almost as if a
- 49:21Speaker 2: technology waiting for a use. And when this rolled out,
- 49:27Speaker 2: to me, one of the greatest blunders was that there
- 49:31Speaker 2: was no way to shut off this genetic code. And so.
- 49:36Speaker 1: What do you mean, no way to shut off once
- 49:37Speaker 1: it's injected into you?
- 49:38Speaker 2: Yes.
- 49:39Speaker 1: So.
- 49:40Speaker 2: Normally cells make messenger RNA. So we have our DNA
- 49:44Speaker 2: and a DNA codes for a message. The messenger RNA
- 49:48Speaker 2: is made. It goes outside the cell and it works
- 49:53Speaker 2: with ribosomes and it makes a protein like insulin. And
- 49:56Speaker 2: then the messenger RNA is immediately dissolved with enzymes. Done.
- 50:00Speaker 2: And so this cycle goes on and on and on.
- 50:03Speaker 2: So the ability to make synthetic messenger RNA is powerful,
- 50:07Speaker 2: but the reason why the, development program stumbled so long
- 50:12Speaker 2: is that it was immediately dissolved by these enzymes. So
- 50:16Speaker 2: Carrico and Wiseman, who won the Nobel Prize in 2023,
- 50:21Speaker 2: I believe, they came up with a process of replacing
- 50:25Speaker 2: one of the base pairs in the code in messenger RNA, uracil,
- 50:30Speaker 2: for a synthetic one called pseudouridine. Once that happened, they
- 50:36Speaker 2: were able to make the messenger RNA indestructible. Human enzymes
- 50:39Speaker 2: can't break it down. Now it's game on.
- 50:43Speaker 1: Now it's ready.
- 50:43Speaker 2: So now you, Carrico and Wiseman, 2023 Nobel Prize.
- 50:47Speaker 1: But this was after COVID had come out.
- 50:49Speaker 2: I know, but the work was, and don't forget, Nobel
- 50:51Speaker 2: Prize is usually granted for 20 years of work. So
- 50:55Speaker 2: they were working on this for years. So Pfizer, Moderna,
- 50:59Speaker 2: when they went through their decision-making on this, They tried,
- 51:03Speaker 2: let's try to just replace 25% of the uracils. Well,
- 51:06Speaker 2: it still gets dissolved. 50% still gets dissolved. 75%. They
- 51:10Speaker 2: finally said, screw it. Replace all of it. Let's make
- 51:13Speaker 2: it fully synthetic. Well, let me tell you what. This
- 51:17Speaker 2: gets injected in the human body. I was alarmed when
- 51:22Speaker 2: that proposal was made. I published an op-ed.
- 51:24Speaker 1: So you have a fully synthetic genetic code inside of you? Yes.
- 51:28Speaker 1: That can't be dissolved?
- 51:29Speaker 2: Cannot be dissolved. That's Pfizer and Moderna. And I published
- 51:33Speaker 2: an op-ed in The Hill, and myself and Scott Atlas
- 51:37Speaker 2: were invited through 2020 to kind of guide a house
- 51:42Speaker 2: in the Senate White House on what's going on with
- 51:44Speaker 2: the pandemic. And I published an op-ed in The Hill
- 51:47Speaker 2: in August of 2020. And the title of the op-ed
- 51:51Speaker 2: is The Great Gamble of the COVID-19 Vaccine Development Program.
- 51:57Speaker 2: So I called it out. I said, listen, This is
- 52:00Speaker 2: a gamble. And when this rolled out, the CDC says, well,
- 52:05Speaker 2: it just stays in the arm and it'll be there
- 52:06Speaker 2: for a couple of days. We have now one of
- 52:09Speaker 2: my patients in Dallas and we've just published it. There
- 52:12Speaker 2: you go. The great gamble. You're looking at the only
- 52:15Speaker 2: public figure in the world who questioned the vaccines before
- 52:19Speaker 2: they came out. The only one. You can't find another
- 52:23Speaker 2: person who put it in writing big time before they
- 52:26Speaker 2: came out. They came out December of 2020. No one did.
- 52:30Speaker 1: PMAC. No one did.
- 52:32Speaker 2: No one else did it. I mean, the point I'm
- 52:35Speaker 2: making is the entire world was seduced by this technology.
- 52:41Speaker 1: For sure.
- 52:42Speaker 2: The seduction was overwhelming. Every country signed on to this.
- 52:46Speaker 2: They couldn't wait to do this.
- 52:48Speaker 1: Can you search that and see if the genetic code
- 52:51Speaker 1: that was injected in with the mRNA vaccines, it doesn't?
- 52:54Speaker 2: Go to McCullough Foundation, McCulloughFND.org, and I'll get you a
- 52:59Speaker 2: link there. But the point is we have one of
- 53:01Speaker 2: my patients. This guy has taken three Pfizer shots. He's
- 53:05Speaker 2: had blood clots, MRI-proven heart damage, neurologic damage. He's absolutely
- 53:12Speaker 2: miserable with these shots. And so we work with a
- 53:15Speaker 2: lab in Germany that can actually detect the spike protein.
- 53:18Speaker 2: And scroll down to our publications. You should find it here.
- 53:23Speaker 1: But this is on your own website.
- 53:24Speaker 2: Yeah, but it links to the publication. Everything I do
- 53:27Speaker 2: is peer-reviewed and published. So that's him right there, actually,
- 53:31Speaker 2: if you want to see him. That's Steve Kempin, the
- 53:37Speaker 2: man right there with the glasses on. He's got Pfizer
- 53:41Speaker 2: circulating in his bloodstream. 3.6 years after the shots. So
- 53:45Speaker 2: it's in his skin. We did skin biopsies. We did
- 53:48Speaker 2: two sets of skin biopsies, multiple sets of blood tests.
- 53:53Speaker 1: Okay. And is this the only patient like this you found?
- 53:56Speaker 2: Well, it's the only, with every seminal observation, he is
- 54:01Speaker 2: the seminal observation. What does that mean? That means the
- 54:05Speaker 2: first one. It's the first observation. There it is. That's
- 54:08Speaker 2: the central figure. This is essentially what we found in
- 54:11Speaker 2: Steve Kempin. So this is the work we're doing at
- 54:13Speaker 2: McCullough Foundation. You know, Harvard's not doing this. Mayo Clinic's
- 54:17Speaker 2: not doing this. There's sick people who took the vaccine.
- 54:20Speaker 2: They are not looking for the spike protein. They're not
- 54:23Speaker 2: looking for the vaccine. They're baffled. You know, the Biden
- 54:27Speaker 2: administration spent a billion dollars on long COVID, never considered
- 54:32Speaker 2: the spike protein, which is the cause of long COVID.
- 54:34Speaker 2: When you get the infection... a part of the spike
- 54:37Speaker 2: protein gets stuck in your body. You take the vaccine,
- 54:40Speaker 2: you get the full-length spike protein in your body. No
- 54:42Speaker 2: wonder you feel sick.
- 54:43Speaker 1: Why wouldn't they be trying to figure it out? Because
- 54:44Speaker 1: there's money there too.
- 54:46Speaker 2: It's the most interesting observation ever. There's no lectures on
- 54:54Speaker 2: the spike protein or vaccine injuries. There's no grand rounds.
- 54:58Speaker 2: There's no primary care updates. The Biden administration spent a
- 55:01Speaker 2: billion dollars on long COVID research They didn't do a
- 55:05Speaker 2: single spike protein or messenger RNA research study. Now we
- 55:09Speaker 2: have a new administration in. They haven't done it. No
- 55:13Speaker 2: one will look directly at the problem in the entire world.
- 55:18Speaker 2: And on top of this, there's plenty of evidence suggesting
- 55:23Speaker 2: each vial was different. Each batch was different. Some were
- 55:25Speaker 2: super loaded. Some didn't have much in it at all.
- 55:28Speaker 2: There's tremendous batch-to-batch variability.
- 55:31Speaker 1: This episode is sponsored by BetterHelp. You know, it's March.
- 55:36Speaker 1: You know it. We can't hide it. And this month,
- 55:40Speaker 1: we're celebrating International Women's Day. And let's take a second
- 55:44Speaker 1: to appreciate some of the strong women in our lives.
- 55:48Speaker 1: It could be a teacher, a sister, a mother, maybe
- 55:52Speaker 1: just a strong boss, maybe a bus driver. You know,
- 55:55Speaker 1: it can be easy to overlook how much women do
- 55:57Speaker 1: for us. And they deserve a place to feel safe
- 56:00Speaker 1: and to take care of their emotional well-being. With over 30,000 therapists,
- 56:05Speaker 1: BetterHelp is the world's largest online therapy platform, having served
- 56:10Speaker 1: over 6 million people globally. And it works. Your emotional
- 56:13Speaker 1: well-being matters. And so does your mother's or your sister's
- 56:17Speaker 1: or any of your female friends. You can find support
- 56:21Speaker 1: for yourself or others and feel lighter with therapy. Sign
- 56:25Speaker 1: up and get 10% off today at betterhelp.com slash Theo.
- 56:30Speaker 1: That's betterhelp.com slash T-H-E-O. Is pornography causing a problem in
- 56:37Speaker 1: your life? Do you find yourself watching porno for longer
- 56:42Speaker 1: periods of time and having trouble stopping? Is porn affecting
- 56:47Speaker 1: your relationship or dating life? Well, you're certainly not alone.
- 56:52Speaker 1: Watching pornography has become so commonplace today and oftentimes men
- 56:57Speaker 1: use porn to numb the pain of loneliness, boredom, anxiety,
- 57:02Speaker 1: and depression. Shame and stigma prevent men from talking about
- 57:06Speaker 1: these issues and getting help for them. I want to
- 57:10Speaker 1: introduce you to my friend Steve. Steve is the founder
- 57:13Speaker 1: of Valor Recovery, a program to help men overcome porn
- 57:16Speaker 1: abuse and sexual compulsivity. Steve is a long-term sexual recovery
- 57:21Speaker 1: member and has personally overcame the emotional and spiritual despair
- 57:25Speaker 1: of abusing pornography and has dedicated his life to empowering
- 57:29Speaker 1: men to do the same. Steve is an amazing person,
- 57:34Speaker 1: and he is a close friend of mine. I mean that.
- 57:38Speaker 1: Valor Recovery helps men to develop the tools necessary to
- 57:41Speaker 1: have a healthier sex life. Their coaches are in long-term
- 57:44Speaker 1: recovery and will be your partner, mentor, and spiritual guide
- 57:49Speaker 1: to transcend these problematic behaviors. To learn more about Valor Recovery,
- 57:54Speaker 1: please visit them at www.valorrecoverycoaching.com or email them at admin
- 58:05Speaker 1: at valorrecoverycoaching.com. Thank you.
- 58:12Speaker 2: Do you know that not a single country has initiated
- 58:16Speaker 2: a safety review of these vaccines? Not a single country
- 58:20Speaker 2: has opened the vials to inspect them for quality or purity?
- 58:24Speaker 2: And not a single country, they're on 140 markets, not
- 58:29Speaker 2: a single country has pulled them off the market.
- 58:32Speaker 1: Why though? And how would you get all of these
- 58:35Speaker 1: countries to go along with this continually and agree? Like
- 58:39Speaker 1: there has to still be some like countries out there
- 58:41Speaker 1: who are willing to raise their hand and ask questions, huh? None.
- 58:45Speaker 2: It's a mind blowing reality. You can't get people to agree.
- 58:51Speaker 2: This is the biggest oblivion.
- 58:54Speaker 1: But you are saying you're getting them all to agree
- 58:56Speaker 1: to not look into this. Yes. How?
- 59:02Speaker 2: I was asked to lecture last year in Chautauqua, which
- 59:06Speaker 2: is actually a great honor. Chautauqua is the heart of...
- 59:10Speaker 2: modern American liberalism. It's in Western New York. The Roosevelt's
- 59:14Speaker 2: have lectured there. And I thought about this. How can
- 59:19Speaker 2: this be? How can not a single medical school have
- 59:24Speaker 2: a spike protein project looking at this? And I picked
- 59:29Speaker 2: two prior examples where there is a complete oblivion to
- 59:35Speaker 2: a big problem. The first one was 1860 to 1920,
- 59:40Speaker 2: what I call the first great cocaine epidemic. Every drug
- 59:45Speaker 2: made by all the pharmaceutical companies was cocaine derivatives. It
- 59:48Speaker 2: was in Coca-Cola. It was in Chianti wine. All the
- 59:51Speaker 2: doctors experimented with this. The nurses used it. All the
- 59:55Speaker 2: medical journals were publishing effects of cocaine, improving energy. JAMA,
- 1:00:01Speaker 2: New England Journal of Medicine, Halstead, the father of modern surgery,
- 1:00:05Speaker 2: used cocaine as an anesthetic. He became a brutal cocaine addict.
- 1:00:09Speaker 2: So did Sigmund Freud.
- 1:00:10Speaker 1: He was on it, huh? Right.
- 1:00:12Speaker 2: So listen, this goes on for 60 years. In JAMA,
- 1:00:18Speaker 2: our U.S. medical journal, in 60 years with hundreds and
- 1:00:21Speaker 2: hundreds and hundreds of papers on cocaine, there was one
- 1:00:24Speaker 2: paper by an Irish doctor who said, I'm concerned this
- 1:00:30Speaker 2: is causing addiction. One in 60 years, a complete oblivion
- 1:00:36Speaker 2: to the addictive potential of cocaine.
- 1:00:39Speaker 1: So you're saying that it's possible.
- 1:00:41Speaker 2: Okay, let me give another example. 1920 to 1978, what
- 1:00:46Speaker 2: I call smoke fest. Everyone smoked. Doctors smoked, nurses smoked,
- 1:00:53Speaker 2: everyone smoked. People in high society, smoke, smoke, smoke, smoke, smoke.
- 1:00:56Speaker 2: Doctors handed out cigarettes in the clinics. RGR Reynolds and
- 1:01:00Speaker 2: American Tobacco Company, Philip Morse, they had doctor.
- 1:01:04Speaker 1: Prescribed cigarettes?
- 1:01:05Speaker 2: No, they had doctor cigarette promotional campaigns where the doctors
- 1:01:08Speaker 2: handed out cigarettes. They said which ones they thought were
- 1:01:10Speaker 2: the best and doctors claiming smoking is safe. This goes
- 1:01:15Speaker 2: on and on and on. And finally, Sir Austin Bradford
- 1:01:20Speaker 2: Hill in the UK, an epidemiologist, and Richard Dahl, a
- 1:01:23Speaker 2: medical doctor, present data in the UK in 1950 that
- 1:01:28Speaker 2: And they said, it looks like smoking causes lung cancer. No,
- 1:01:32Speaker 2: you can't be– you're smeared and discredited, debunked. Loser. If
- 1:01:37Speaker 2: it was social media, they would have been canceled. They
- 1:01:40Speaker 2: would have been thrown off YouTube for saying that smoking
- 1:01:42Speaker 2: causes lung cancer. They do the physician smoking study. They
- 1:01:46Speaker 2: come back four years later. They said, listen, smoking is
- 1:01:49Speaker 2: causing cancer. In fact, half of British doctors are dying
- 1:01:52Speaker 2: of smoking-related conditions. still doesn't convince them. In the United States,
- 1:01:57Speaker 2: this goes all the way to 1964. Luther Terry, our
- 1:02:01Speaker 2: Surgeon General, calls a meeting to Washington of the doctors
- 1:02:05Speaker 2: and says, listen, I got the Surgeon General's report. Smoking
- 1:02:09Speaker 2: causes lung cancer. Doctors were still smoking. They still didn't
- 1:02:12Speaker 2: believe him. In fact, doctors were smoking in the operating room,
- 1:02:17Speaker 2: in the clinic. A great book is The Emperor of
- 1:02:20Speaker 2: All Maladies by Mukherjee, one that Pulitzer Prizes in his
- 1:02:23Speaker 2: first book, He describes the lead surgeon at Johns Hopkins
- 1:02:27Speaker 2: taking out these blackened lung cancers in surgery. And he
- 1:02:32Speaker 2: was smoking all the time when he was doing the
- 1:02:34Speaker 2: surgery and teaching the students, no, smoking doesn't– the black
- 1:02:37Speaker 2: smoke doesn't cause the lung cancer. He himself dies of
- 1:02:41Speaker 2: lung cancer. And on his deathbed, he still says that
- 1:02:43Speaker 2: smoking doesn't cause lung cancer. It's not until 1978 before
- 1:02:47Speaker 2: the AMA sheepishly comes out with its first brochure, The Dangers,
- 1:02:52Speaker 2: Health Hazards of Smoking. And it's not until the 1990s
- 1:02:56Speaker 2: before we have the tobacco settlement. So my point is, listen,
- 1:03:00Speaker 2: if cocaine and the doctors being totally oblivious to cocaine
- 1:03:04Speaker 2: because they were seduced by it, totally oblivious to smoking
- 1:03:07Speaker 2: because they were seduced by it, and now totally oblivious
- 1:03:10Speaker 2: to the hazards of these COVID vaccines. We got three
- 1:03:14Speaker 2: examples here. What's common to all of them? Self-participation. That is,
- 1:03:20Speaker 2: they did it themselves. Can you imagine if you told
- 1:03:22Speaker 2: a doctor, listen, did you take the Pfizer, Moderna vaccines? Yeah.
- 1:03:26Speaker 2: Do you know they don't leave the body and they're
- 1:03:28Speaker 2: still in your body now producing spike protein? No. And no,
- 1:03:32Speaker 2: I don't know and I don't want to know. And
- 1:03:34Speaker 2: did you have your wife and your family take it? Oh, yeah,
- 1:03:36Speaker 2: I did. And did you tell your patients to take it?
- 1:03:38Speaker 1: Yeah.
- 1:03:39Speaker 2: Do you know it causes fatal heart damage and blood clots?
- 1:03:42Speaker 2: and autoimmune problems, neurologic problems, stroke, and it may cause cancer,
- 1:03:47Speaker 2: it's overwhelming. The average doctor cannot psychologically handle it, just
- 1:03:53Speaker 2: like they couldn't psychologically handle it that cocaine was damaging
- 1:03:56Speaker 2: themselves and ruining their lives, or like smoking was causing
- 1:03:59Speaker 2: their lung cancer. It's the same thing. Wow.
- 1:04:02Speaker 1: Yeah, I guess when you look at it like that,
- 1:04:03Speaker 1: that it's happened throughout time, that if we've been standing
- 1:04:06Speaker 1: right there in the sun and denying light, it's pretty wild.
- 1:04:11Speaker 1: What are some of those common side effects that you've
- 1:04:13Speaker 1: seen from the COVID-19 vaccines?
- 1:04:14Speaker 2: Most concerning is fatal heart damage, myocarditis, fatal.
- 1:04:20Speaker 1: What is myocarditis? We hear about it all the time.
- 1:04:21Speaker 1: People are like, you know, a kid falls down in
- 1:04:24Speaker 1: a soccer game and people are yelling, he's got myocarditis.
- 1:04:27Speaker 1: You know, you just don't know what's going on. What
- 1:04:29Speaker 1: is it exactly?
- 1:04:29Speaker 2: There was a very important paper by Crosson, K-R-A-U-S-O-N, from
- 1:04:36Speaker 2: Harvard that found in some people who took the vaccines
- 1:04:40Speaker 2: that found that the messenger RNA is physically in the heart.
- 1:04:44Speaker 2: That's a bad sign. Whatever you take in the arm
- 1:04:47Speaker 2: should not end up in the heart. So it has
- 1:04:50Speaker 2: a tropism for the heart. It actually has a predilection
- 1:04:52Speaker 2: to go in the heart. So there's crossing to 2023.
- 1:04:58Speaker 2: So messenger RNA is in the heart. Let me see.
- 1:05:02Speaker 1: Duration of SARS-CoV-2 mRNA vaccine. Persistence and factors associated with
- 1:05:06Speaker 1: the cardiac involvement in recently vaccinated patients. Let me see
- 1:05:14Speaker 1: what it says. Vaccine was detected in the axillary lymph
- 1:05:17Speaker 1: nodes in a majority of patients dying within 30 days
- 1:05:20Speaker 1: of vaccination, but not in patients dying more than 30
- 1:05:23Speaker 1: days from vaccination. So originally it was going.
- 1:05:26Speaker 2: To the heart. Read farther down. Vaccine was detected in
- 1:05:30Speaker 2: the myocardium, in the heart, in a subset of patients
- 1:05:33Speaker 2: vaccinated within 30 days of death. I mean, it's at
- 1:05:36Speaker 2: the scene of the crime, okay? Right. Another paper by Baumeier, B-A-U-M-E-I-E-R,
- 1:05:45Speaker 2: Baumeier found the spike protein in the heart. He didn't
- 1:05:49Speaker 2: have the tech to find the messenger RNA, but he
- 1:05:51Speaker 2: found the spike protein in the heart. And there you go.
- 1:05:55Speaker 2: That should be Baumeier. That's it. So this is image.
- 1:05:58Speaker 2: These are images showing inflammation and spike protein in the heart.
- 1:06:03Speaker 2: So here's the point. The vaccine is in the heart.
- 1:06:07Speaker 2: The spike protein is the heart. When you have inflammation
- 1:06:10Speaker 2: in the heart, the heart is dependent on having a nice,
- 1:06:14Speaker 2: consistent muscle for conduction of electricity. That's how our heartbeat comes, depolarization.
- 1:06:20Speaker 2: When you have inflammation, that creates heterogeneity in conduction, and
- 1:06:24Speaker 2: then we can actually get a re-entrant loop, an electrical
- 1:06:27Speaker 2: loop that goes around very, very fast. That's called ventricular tachycardia.
- 1:06:31Speaker 2: And if that isn't shocked or interrupted, it degenerates to
- 1:06:35Speaker 2: ventricular fibrillation, and you're down. Now, the triggers, we've had
- 1:06:41Speaker 2: myocarditis rarely before the pandemic from various viruses and other
- 1:06:47Speaker 2: forms of inflammation. It was known then that we can
- 1:06:51Speaker 2: never let these people exercise because if they exercise, the
- 1:06:55Speaker 2: surge of adrenaline through exercise can trigger this abnormal heart rhythm.
- 1:07:00Speaker 2: It's in our guidelines. So as the vaccines roll out,
- 1:07:05Speaker 2: and we've had a U.S. Senate hearing on this In
- 1:07:09Speaker 2: May of 2025, people started getting heart damage with the vaccines.
- 1:07:14Speaker 2: And if you look up U.S. Senate testimony, May 21st, 2026,
- 1:07:18Speaker 2: Ron Johnson, Peter McCullough. The U.S. government got communications from
- 1:07:33Speaker 2: Israel saying, listen, we gave the vaccine to all our soldiers.
- 1:07:36Speaker 2: We got 60 cases of heart damage and two cases
- 1:07:39Speaker 2: are fatal. This came in in February of 2021. The
- 1:07:44Speaker 2: public health agencies, they all sat on this. The White
- 1:07:49Speaker 2: House sat on this and they didn't inform the public.
- 1:07:52Speaker 2: And so more people got vaccinated. Then a big bomb hit,
- 1:07:57Speaker 2: and the bomb hit, that's my opening statement right there,
- 1:08:00Speaker 2: a big bomb hit in August of 2021, where a
- 1:08:08Speaker 2: paper was published from Washington University in St. Louis. First
- 1:08:12Speaker 2: author is Verma, V-E-R-M-A. And they describe a 42-year-old man
- 1:08:20Speaker 2: who takes a Moderna shot, develops myocarditis, gets really sick,
- 1:08:24Speaker 2: goes in the hospital, And he dies right in front
- 1:08:26Speaker 2: of them. They can't save him. With all the technology
- 1:08:29Speaker 2: that we have, life support systems, everything else, he dies. Brutal,
- 1:08:34Speaker 2: fatal myocarditis. And this is New England Journal of Medicine.
- 1:08:42Speaker 2: But here's my point. If there was a new drug
- 1:08:44Speaker 2: on the market and we gave it to somebody and
- 1:08:47Speaker 2: they died of fatal heart damage, there'd be product warnings, withdrawals.
- 1:08:52Speaker 2: Doctors would say, wait a minute, I'm not concerned. Doctors
- 1:08:57Speaker 2: showed no concern over this, outside of me. I saw this.
- 1:09:00Speaker 2: I said, you got to be kidding me. This kills
- 1:09:03Speaker 2: a healthy 42-year-old man. If Moderna can kill a healthy
- 1:09:08Speaker 2: 42-year-old man with all the technology and we can't save him,
- 1:09:12Speaker 2: do you know how many people are dying in nursing homes,
- 1:09:15Speaker 2: in athletic fields, and in schools? and all over, and
- 1:09:19Speaker 2: how many people are dying in underdeveloped countries.
- 1:09:23Speaker 1: But are we seeing an uptick in that? Like, is
- 1:09:25Speaker 1: there any information, or would we even get the correct
- 1:09:28Speaker 1: information anymore? Because it starts to get to this place
- 1:09:31Speaker 1: where you're like, okay, if this is really happening, I'm
- 1:09:33Speaker 1: not seeing people drop dead everywhere, you know? I'm not
- 1:09:37Speaker 1: hearing that, but also you don't know if the news
- 1:09:39Speaker 1: is factual or not a lot of times. Don't you
- 1:09:43Speaker 1: think you would see, like, see it happening in mass
- 1:09:46Speaker 1: so that it would really support some of this information
- 1:09:48Speaker 1: that you're saying?
- 1:09:50Speaker 2: You'd have to get to a point where it would be,
- 1:09:58Speaker 2: people have estimated this, what would be something so significant
- 1:10:02Speaker 2: that you'd see it with your human eye? It's probably
- 1:10:05Speaker 2: more than 15%.
- 1:10:08Speaker 1: More than 15% of the population, you mean?
- 1:10:10Speaker 2: You'd have to just see bodies all over the place.
- 1:10:13Speaker 1: Yeah, you'd literally have to be like, oh, man, what's
- 1:10:15Speaker 1: going on?
- 1:10:16Speaker 2: Otherwise, you'll miss an important signal. Now, there's 12 studies
- 1:10:20Speaker 2: showing mortality is actually up since the pandemic, not down.
- 1:10:25Speaker 2: You go through a pandemic, there's a culling effect. There
- 1:10:27Speaker 2: should be sicker, frail people who die, and therefore, the
- 1:10:31Speaker 2: remaining people have a lower mortality if the pandemic mortality
- 1:10:34Speaker 2: is up.
- 1:10:35Speaker 1: Do you believe that the number of vaccine-related deaths is
- 1:10:37Speaker 1: being misrepresented? Yes.
- 1:10:40Speaker 2: So let's go to Open VAERS. Open VAERS. O-P-E-N-V-A-E-R-S dot com.
- 1:10:47Speaker 2: Click U.S. data. Okay, nobody's challenged this. This is presented
- 1:10:52Speaker 2: in the U.S. Senate multiple times. These are deaths reported
- 1:10:56Speaker 2: to VAERS by doctors like me who've already determined the
- 1:10:59Speaker 2: vaccine is the cause of death. This is not controversial.
- 1:11:01Speaker 2: I've reported some of these cases. I've already decided The
- 1:11:04Speaker 2: vaccine caused the death. I filed the death certificate. I've
- 1:11:08Speaker 2: looked at the autopsy. I've looked at the MRIs. I've
- 1:11:10Speaker 2: looked at all the data. This is not up to
- 1:11:12Speaker 2: the CDC to decide. I've decided, okay? 16, 19,609 deaths. Okay.
- 1:11:19Speaker 2: Do you know how many deaths per year come into
- 1:11:26Speaker 2: this system for all the other vaccines combined? 150. 150,000?
- 1:11:32Speaker 1: 150. Total.
- 1:11:34Speaker 2: Total.
- 1:11:35Speaker 1: Wow.
- 1:11:35Speaker 2: This is off the Richter scale. Off the Richter scale.
- 1:11:40Speaker 2: And so in Senate and House and Senate and FDA testimony,
- 1:11:46Speaker 2: people said, wait a minute, if you don't have the
- 1:11:47Speaker 2: vaccine card and you're not willing to report it and
- 1:11:51Speaker 2: you don't have all the data, it can't be reported.
- 1:11:54Speaker 2: So what is the underreporting factor? There's actually a publication
- 1:11:56Speaker 2: on this. But from you, from conservatively, because people are
- 1:12:00Speaker 2: aware of COVID and fatal side effects, The conservative estimate
- 1:12:04Speaker 2: is 30. And in my publications, I use 30.
- 1:12:07Speaker 1: 30,000?
- 1:12:07Speaker 2: No, 30. It's an underreporting factor. Meaning this 19,609 is
- 1:12:16Speaker 2: probably underreported 30-fold. So the true number of vaccine deaths
- 1:12:20Speaker 2: is between 500 and 600,000 deaths. No way. Yeah.
- 1:12:24Speaker 1: Wow. And how do you get that 30x?
- 1:12:27Speaker 2: Well, there's a paper by Lazarus that said it's 100.
- 1:12:29Speaker 2: It's 100-fold underreported. People said no. People know about these
- 1:12:33Speaker 2: COVID vaccines. So we are reporting more deaths now than
- 1:12:37Speaker 2: other vaccines. But 30-fold underreported is conservative. It's conservative. But
- 1:12:42Speaker 2: even if there's no underreporting, 19,609. What if we had 19,609
- 1:12:45Speaker 2: people die from a new energy drink? Yeah. People would
- 1:12:47Speaker 2: be outraged. Like Prime or whatever.
- 1:12:48Speaker 1: Right?
- 1:12:48Speaker 2: Yeah. You know, we have a couple of people die
- 1:13:00Speaker 2: in a building collapse. It makes the news. You know,
- 1:13:04Speaker 2: you have Nancy Guthrie, bless her heart, she's abducted from
- 1:13:08Speaker 2: her home. It's on the news for weeks on end.
- 1:13:12Speaker 1: Yeah, Cash Patel can't even find her. He's out partying
- 1:13:14Speaker 1: or whatever. No, but what I mean is one death
- 1:13:17Speaker 1: is too many. But here we are. Here we are.
- 1:13:21Speaker 2: In that 19,609, are these in-your-face deaths reported in the
- 1:13:26Speaker 2: peer-reviewed literature? And one that really caught my eye is
- 1:13:28Speaker 2: by Gill and colleagues. Gill, Archives of Pathology. This is terrible.
- 1:13:33Speaker 2: This is two boys. They're teenagers. They die after taking Pfizer.
- 1:13:41Speaker 2: And they're found, yes, Gill, they're found in their beds,
- 1:13:45Speaker 2: dead at home by their parents. They get autopsies. They
- 1:13:49Speaker 2: bring an expert pathologist. It's conclusive. They died of taking
- 1:13:54Speaker 2: the Pfizer vaccine. Healthy young adolescents.
- 1:13:57Speaker 1: Let me read this. Clinical and autopsy investigation of two
- 1:13:59Speaker 1: teenage boys who died shortly following administration of the second
- 1:14:02Speaker 1: Pfizer BioNTech COVID-19 dose. The myocardial injury seen in these
- 1:14:08Speaker 1: post-vaccine hearts is different from typical myocarditis and has an
- 1:14:11Speaker 1: appearance most closely resembling a catacomb. polamine-mediated stress cardiomyopathy. Understanding
- 1:14:20Speaker 1: these instances are different from typical myocarditis and that cytokine
- 1:14:24Speaker 1: storm has a known feedback loop.
- 1:14:26Speaker 2: Do you want me to translate? Yeah.
- 1:14:29Speaker 1: Okay.
- 1:14:31Speaker 2: I mentioned that- It's that electrical loop you were talking about. Wait,
- 1:14:33Speaker 2: I mentioned the vaccine is in the heart, the spike
- 1:14:35Speaker 2: protein is in the heart, there's inflammation. But what triggers
- 1:14:38Speaker 2: the cardiac arrest is a surge of adrenaline. That occurs
- 1:14:41Speaker 2: on the playing field during athletics. It also occurs between
- 1:14:44Speaker 2: 3 a.m. and 6 a.m. during the normal waking hours
- 1:14:47Speaker 2: of sleep, called the waking hours. That's what happens. So
- 1:14:50Speaker 2: the pattern of vaccine deaths has been during sports and
- 1:14:54Speaker 2: athletics and then dead in bed. These are astronomical numbers.
- 1:15:00Speaker 1: The simple fact that 150 people have died of vaccines
- 1:15:04Speaker 1: each year, right? Is that what you're saying?
- 1:15:06Speaker 2: That's what comes in the report.
- 1:15:07Speaker 1: Right. And- This report is saying that there was 19,000,
- 1:15:14Speaker 1: which we believe is highly underreported.
- 1:15:16Speaker 2: Right, 19,000 over five years. But I can tell you,
- 1:15:21Speaker 2: by March of 2021, three months into the campaign, there
- 1:15:26Speaker 2: were 1,600 deaths. And I was called to the Texas Senate.
- 1:15:31Speaker 2: I said, listen, I'm concerned. I had already expressed concern
- 1:15:34Speaker 2: before they came out. I'm really concerned. And you can't
- 1:15:43Speaker 2: whitewash this away. And that's what we saw being done everywhere.
- 1:15:48Speaker 2: And I've heard ridiculous explanations like, well, these aren't verified. Well,
- 1:15:55Speaker 2: who's going to verify them? The doctor has all the right.
- 1:15:58Speaker 2: When I do a VAERS report, the first three or
- 1:16:01Speaker 2: four pages is all about me. Who are you? Who's
- 1:16:04Speaker 2: making this report? Where's your name? What's your address? What's
- 1:16:07Speaker 2: your email? What's your office address? What have you?
- 1:16:09Speaker 1: Okay.
- 1:16:10Speaker 2: Then the next several pages are who the patient? Who
- 1:16:12Speaker 2: are they? Who are their relatives? Where's their email? What's
- 1:16:15Speaker 2: their address? The CDC has all of this information on 19,000 deaths.
- 1:16:22Speaker 2: Do you know how many people the CDC has actually
- 1:16:25Speaker 2: called to kind of do a study? Zero.
- 1:16:28Speaker 1: Wow.
- 1:16:30Speaker 2: They're sitting on 19,600 deaths. They have all the information.
- 1:16:36Speaker 2: They didn't even send a, you know, a I'm sorry card.
- 1:16:41Speaker 2: I mean, let alone do a study.
- 1:16:45Speaker 1: I mean, to think that the Center for Disease Control,
- 1:16:48Speaker 1: we're so diseased. We're one of the most diseased countries
- 1:16:51Speaker 1: in existence. How they're even still allowed to function to
- 1:16:55Speaker 1: me is just beyond me. I think most people, I'm
- 1:16:58Speaker 1: seeing an uptick of people that want to give births
- 1:17:00Speaker 1: in home, people that do not want to go to
- 1:17:02Speaker 1: the hospital anymore, people looking for home remedies, homeopathic type
- 1:17:07Speaker 1: of remedies, people trying to get off of their antidepressants.
- 1:17:10Speaker 1: I mean, I think it's one of the largest resurgences.
- 1:17:14Speaker 1: There's more people getting into homeschooling right now than there
- 1:17:19Speaker 1: was during COVID, right? If you think about that, that's unbelievable.
- 1:17:24Speaker 1: That's how much people do not trust any of these
- 1:17:27Speaker 1: entities anymore.
- 1:17:28Speaker 2: Well, have you heard that there's measles outbreaks everywhere?
- 1:17:31Speaker 1: I haven't seen it.
- 1:17:32Speaker 2: Yeah, it's all over. Oh, my gosh.
- 1:17:34Speaker 1: Is it true?
- 1:17:35Speaker 2: Well, you know, there are now there's one of the
- 1:17:40Speaker 2: social media platforms. It's called Threads. Do you know what
- 1:17:45Speaker 2: Threads is?
- 1:17:46Speaker 1: Oh, yeah.
- 1:17:47Speaker 2: So go on Threads.
- 1:17:48Speaker 1: I don't think we have a Threads account, though.
- 1:17:50Speaker 2: Oh, I do. But anyhow, you go on threads, every
- 1:17:53Speaker 2: time you turn around, there's a measles update, another measles outbreak,
- 1:17:57Speaker 2: another measles outbreak.
- 1:17:58Speaker 1: That's interesting that that's where it's at too. Nobody's even
- 1:18:00Speaker 1: on threads.
- 1:18:02Speaker 2: So of interest, we have about 1,000 measles cases so
- 1:18:07Speaker 2: far this year. In average years, about 2,000 in the
- 1:18:09Speaker 2: United States. There have been 40,000 distinct press pieces on
- 1:18:17Speaker 2: measles outbreaks. Wow. And 75% of those encourage taking the
- 1:18:24Speaker 2: measles vaccine. So this is interesting. And so, and by
- 1:18:27Speaker 2: the way, in the pieces, they blame RFK and Trump.
- 1:18:32Speaker 2: Now think about this. RFK and Trump have been in office, what,
- 1:18:35Speaker 2: a year and three months. A baby doesn't come up
- 1:18:39Speaker 2: for the first measles vaccine until about 18 months of age.
- 1:18:44Speaker 2: So the measles cases are seen now. And so the
- 1:18:47Speaker 2: most ridiculous thing is.
- 1:18:49Speaker 2: They'll say measles outbreak hits college campus. So why don't
- 1:18:54Speaker 2: you type in measles outbreaks? There have been some measles
- 1:18:56Speaker 2: cases on college campuses. And they'll say, you know, they'll
- 1:19:00Speaker 2: blame RFK and Trump. Say, wait a minute, that kid's
- 1:19:04Speaker 2: vaccine decision occurred 15 years ago. How can they blame Trump?
- 1:19:08Speaker 2: And so there you go, hits the university in Florida.
- 1:19:11Speaker 1: Oh, yeah, Florida, UMass Amherst. I've caught something over there.
- 1:19:15Speaker 2: Okay, so here's another point. There have been measles outbreaks
- 1:19:19Speaker 2: recently in the UK. So in the UK, well, how
- 1:19:23Speaker 2: can you blame Trump and RFK? It's the UK. They
- 1:19:27Speaker 2: have a different vaccine schedule. So here's the point I'm
- 1:19:29Speaker 2: making is, And I wrote a sub-stack on this recently
- 1:19:34Speaker 2: that if you go to thefocalpoints.com, I'll give you the
- 1:19:40Speaker 2: update numbers, that we have a situation where testing has
- 1:19:47Speaker 2: been ramped up fourfold. Now they're just doing PCR testing
- 1:19:51Speaker 2: for measles all over. And it turns out the measles
- 1:19:54Speaker 2: vaccine isn't perfect. So in a paper by Bianchi and colleagues,
- 1:19:58Speaker 2: They found about 20% of people who take the measles vaccine,
- 1:20:01Speaker 2: they don't have any serologic protection. I'm one of them.
- 1:20:03Speaker 2: I took the first shot. I took a second shot.
- 1:20:06Speaker 2: I went to medical school. I got a blood test.
- 1:20:08Speaker 2: I took four measles. I still don't have any. I
- 1:20:11Speaker 2: guarantee if I got exposed to measles, I would get it.
- 1:20:15Speaker 2: So it's not perfect. But the measles is being used
- 1:20:18Speaker 2: as an example to try to, in this whole vaccine
- 1:20:22Speaker 2: promotional world, which has divided people into vaxxers and anti-vaxxers.
- 1:20:27Speaker 2: Have you heard that one?
- 1:20:28Speaker 1: For sure.
- 1:20:28Speaker 2: Are you an anti-vaxxer?
- 1:20:31Speaker 1: No, I mean, I got vaccines when I was young.
- 1:20:33Speaker 1: I didn't get the COVID one, but I don't, I'm
- 1:20:38Speaker 1: curious about the science. And I think I don't trust
- 1:20:41Speaker 1: the entities that tell us the things we need to
- 1:20:43Speaker 1: do to take care of ourselves anymore. So I think
- 1:20:45Speaker 1: everything should be put under a microscope right now.
- 1:20:47Speaker 2: Yeah.
- 1:20:48Speaker 1: And I think people should trust their own decision-making. And
- 1:20:50Speaker 1: if that's wrong or right, then at least you as
- 1:20:52Speaker 1: a human can live with that as opposed to feeling
- 1:20:55Speaker 1: like you may have gotten poisoned because then that's out
- 1:20:58Speaker 1: of your then that's not your choice, really.
- 1:21:01Speaker 2: Well, sure. And, you know, I think the unique thing
- 1:21:03Speaker 2: about vaccines is they've been, and we point this out
- 1:21:06Speaker 2: in my book, they've been proposed to essentially be a
- 1:21:11Speaker 2: savior to humanity. And that you get a vaccine to
- 1:21:14Speaker 2: protect other people. And in many ways, that's a myth.
- 1:21:18Speaker 2: The real reason to get a vaccine is for your
- 1:21:21Speaker 2: own personal protection. So it must be a personal choice.
- 1:21:24Speaker 1: I think it is.
- 1:21:24Speaker 2: Just like you take a blood pressure medicine to lower
- 1:21:26Speaker 2: your personal blood pressure. You're not doing it for somebody else.
- 1:21:29Speaker 2: You're doing it for yourself. But vaccines have been presented that,
- 1:21:32Speaker 2: wait a minute, this is good for humanity. And people
- 1:21:37Speaker 2: should do it. And if you're against doing it, you're hesitant.
- 1:21:42Speaker 2: Wait a minute, vaccine hesitancy, that's actually a psychiatric disease.
- 1:21:45Speaker 2: Do you know there's 20- Are you serious? Yeah, there's
- 1:21:47Speaker 2: 20 scientific survey instruments to assess your vaccine hesitancy. And
- 1:21:53Speaker 2: if you score above a certain level, you have a disease.
- 1:21:55Speaker 1: Nuh-uh.
- 1:21:56Speaker 2: Yes.
- 1:21:56Speaker 1: Bring that up, vaccine hesitancy.
- 1:21:58Speaker 2: Yeah, put up McCullough vaccine hesitancy. I just published a
- 1:22:00Speaker 2: paper on this. It's on the Substack. You'll find everything
- 1:22:03Speaker 2: on Substack or my Twitter, you guys. Okay, that's it.
- 1:22:07Speaker 1: Throughout history, there's always been, but this is just you
- 1:22:09Speaker 1: writing it, but this is real information.
- 1:22:10Speaker 2: It's peer reviewed.
- 1:22:11Speaker 1: Okay. Throughout history, there's always been a fear of untreatable,
- 1:22:16Speaker 1: potentially fatal communicable disease. Immunization has been an advancement in
- 1:22:20Speaker 1: population health that has developed over three centuries. However, fear
- 1:22:23Speaker 1: of side effects is a psychological phenomenon that has arisen
- 1:22:27Speaker 1: as a substantial issue for the lay public. Vaccine hesitancy,
- 1:22:31Speaker 1: a complex phenomenon rooted in historical resistance to immunization, poses
- 1:22:35Speaker 1: significant challenges as a concept to the research and public
- 1:22:39Speaker 1: health communities. Who decided vaccine hesitancy was real? Or are
- 1:22:43Speaker 1: you just saying it?
- 1:22:44Speaker 2: 18th century. It goes back to the 1700s.
- 1:22:45Speaker 1: Vaccine hesitancy, a complex phenomenon rooted in historical resistance to immunization. Yeah.
- 1:22:53Speaker 2: And in the paper, I identified 20 different of these measures.
- 1:22:58Speaker 2: You know, there's an Oxford measurement of vaccine hesitancy. And
- 1:23:03Speaker 2: it's just, yeah. So the idea is it actually you're
- 1:23:06Speaker 2: considered to have a psychiatric disease if you are hesitant
- 1:23:12Speaker 2: to take a vaccine. That's how far this has gone. And,
- 1:23:15Speaker 2: you know, people say, well, it was really hard during COVID.
- 1:23:18Speaker 2: I lost my job, what have you. In our book,
- 1:23:20Speaker 2: we point out that this is the late 18th century,
- 1:23:23Speaker 2: let's say about 1790 or so, and some of these
- 1:23:27Speaker 2: smallpox outbreaks, and clearly in the late 19th century, you know,
- 1:23:32Speaker 2: 1890 or so, if you decline taking a vaccine Or
- 1:23:36Speaker 2: your children, your children go to jail. Families went to jail.
- 1:23:40Speaker 2: Parents went to jail. This was enormous. This has gone
- 1:23:45Speaker 2: on for a long time now.
- 1:23:47Speaker 1: So- Well, vaccine hesitancy is not a disease itself, but
- 1:23:50Speaker 1: is a formal medical and sociobiological term used to describe
- 1:23:54Speaker 1: the delay in acceptance and refusal of vaccines. That makes sense.
- 1:23:57Speaker 1: The term was solidified by the WHO SAGE Working Group
- 1:24:00Speaker 1: on Vaccine Hesitancy, which was established in 2012.
- 1:24:04Speaker 2: Right. Listen, pull up the statement by the WHO. It
- 1:24:07Speaker 2: should come down here where the WHO says that vaccine
- 1:24:12Speaker 2: hesitancy is a major threat to public health.
- 1:24:16Speaker 1: They might have even been in that first thing you
- 1:24:18Speaker 1: put up.
- 1:24:18Speaker 2: Yeah. It's a major threat to public health. And so
- 1:24:22Speaker 2: vaccine hesitancy is basically put forward as a principle that
- 1:24:30Speaker 2: that there is top 10 threats to public health if
- 1:24:33Speaker 2: you're hesitant to take a vaccine.
- 1:24:35Speaker 1: In 2019, the World Health Organization officially named vaccine hesitancy
- 1:24:37Speaker 1: as one of the top 10 threats to global health.
- 1:24:40Speaker 1: This designation was a landmark moment because it shifted the
- 1:24:42Speaker 1: focus from the vaccines themselves to the behavioral and social
- 1:24:45Speaker 1: factors that prevent people from using them.
- 1:24:48Speaker 2: Okay, but I told you about our government covering up,
- 1:24:53Speaker 2: and this is like in the U.S. Senate, Homeland Security
- 1:24:56Speaker 2: government files permanent subcommittee investigations. This is airtight. our government
- 1:25:01Speaker 2: covered up heart damage with the COVID vaccines because they
- 1:25:05Speaker 2: didn't want to promote vaccine hesitancy by telling people the facts.
- 1:25:10Speaker 1: Well, sure. I mean, I think that it's all part
- 1:25:12Speaker 1: of the same thing. It's like, well, if we show
- 1:25:14Speaker 1: this and it's going to make people weary of vaccines.
- 1:25:16Speaker 2: I mean, in our society, safety comes first. It doesn't
- 1:25:22Speaker 2: matter how good these vaccines are. It doesn't matter what
- 1:25:27Speaker 2: they could possibly do. If they're not safe, They should go.
- 1:25:31Speaker 1: Well, our safety only comes first to us and sometimes
- 1:25:34Speaker 1: even then. But it obviously does not come first. It
- 1:25:37Speaker 1: doesn't feel like any more to any of these powers
- 1:25:39Speaker 1: that be.
- 1:25:40Speaker 2: Well, does safety come first in automobiles? Yes, because you
- 1:25:44Speaker 2: have all these inspections. Does safety come first when you
- 1:25:46Speaker 2: build your house? You can't get your certificate until things
- 1:25:49Speaker 2: are safe and engineering. Does safety come first in other areas? Yes,
- 1:25:53Speaker 2: except vaccines because vaccines have become a religion. They are
- 1:26:01Speaker 2: accepted as articles of faith. This has been going on
- 1:26:04Speaker 2: for 300 years. It's a religious thing. So if you
- 1:26:08Speaker 2: come in and you say something that violates somebody's religious beliefs,
- 1:26:13Speaker 2: you know what they do? If they're nice to you,
- 1:26:15Speaker 2: you know what they do? They give you the Heisman.
- 1:26:17Speaker 2: They say, I don't want to talk about it. That's
- 1:26:20Speaker 2: what most of my colleagues do. I don't want to
- 1:26:22Speaker 2: talk about it. And if you go further, you know
- 1:26:24Speaker 2: what they normally do? Happened to me, obviously. They throw
- 1:26:28Speaker 2: you out. They say, listen. you're anti-religious, you're sacrilegious, get out.
- 1:26:34Speaker 1: Well, here's the thing. This wouldn't be on so many
- 1:26:36Speaker 1: people's emotional radar and truth radar if there wasn't some
- 1:26:41Speaker 1: truth to it.
- 1:26:41Speaker 2: Correct.
- 1:26:42Speaker 1: Like that to me is undeniable. Like I've always trusted
- 1:26:45Speaker 1: my instincts, right? Sometimes I'm wrong, but over time I
- 1:26:47Speaker 1: hone them. And a lot of times they get very
- 1:26:50Speaker 1: keen for me and I operate well with them, right?
- 1:26:53Speaker 1: And I assume that's how most people operate.
- 1:26:55Speaker 2: Yes. You mentioned you didn't take the COVID vaccines.
- 1:26:58Speaker 1: Yeah.
- 1:26:59Speaker 2: I didn't take them either. And according to USA Facts,
- 1:27:01Speaker 2: which takes the tabular data from the CDC, the best
- 1:27:05Speaker 2: estimates are that 19% of us did not take the shots, 19%. Now,
- 1:27:11Speaker 2: 81% took at least one shot, but only 70% took
- 1:27:16Speaker 2: two shots. So only 70% got fully vaccinated.
- 1:27:21Speaker 1: Ah, understood. I'll say this. We had a guy on
- 1:27:24Speaker 1: last week, this guy James Lee, and he investigates a
- 1:27:27Speaker 1: lot of– He exposes a lot of corruption and he
- 1:27:31Speaker 1: exposes a lot of like rich people that are just
- 1:27:34Speaker 1: being like deviant, you know, type of stuff. You know, companies, politicians,
- 1:27:40Speaker 1: all that, you know, he's seeking out like, he's known
- 1:27:43Speaker 1: for investigations into like corruption and fraud. He was working
- 1:27:47Speaker 1: as a consultant for one of these big biotech companies.
- 1:27:51Speaker 1: And he said there was a conference call at one
- 1:27:53Speaker 1: point where a representative from the company was talking about
- 1:27:58Speaker 1: how They had, everyone had been vaccinated that was going
- 1:28:01Speaker 1: to get vaccinated. They, they kind of figured that. And
- 1:28:05Speaker 1: then there were still a lot of, uh, vaccinations left.
- 1:28:09Speaker 1: It was a stockpile of vaccinations left. And so that
- 1:28:13Speaker 1: they were going to start to push this idea that
- 1:28:14Speaker 1: you needed a further, like a re because there was extra, right?
- 1:28:20Speaker 1: Not because they thought that people really needed it, but
- 1:28:22Speaker 1: because there was extra, do you think something like that
- 1:28:25Speaker 1: could be true?
- 1:28:25Speaker 2: Oh, for sure. Do you know that the pharmacies did
- 1:28:30Speaker 2: not have any blanking period after someone got a shot?
- 1:28:33Speaker 1: Like, what do you mean? There was no timeline between
- 1:28:37Speaker 1: when they should get a second one? Yeah.
- 1:28:39Speaker 2: The primary series is you get one shot, and then
- 1:28:43Speaker 2: two to four weeks later, you get a second shot.
- 1:28:45Speaker 2: But after that, the idea is, well, six months or
- 1:28:51Speaker 2: a year, ultimately it was decided that there were going
- 1:28:53Speaker 2: to be annual shots. But the pharmacies didn't mind giving
- 1:28:57Speaker 2: you extra shots because So I had some patients came
- 1:28:59Speaker 2: in and they were upstanding citizens and they said, Dr. McCullough,
- 1:29:04Speaker 2: we got our COVID shots. And I was like, oh boy,
- 1:29:06Speaker 2: you know, hope you're okay. They said, well, yeah, we're fine,
- 1:29:09Speaker 2: but we're going to go on a cruise. So we
- 1:29:11Speaker 2: went in and got some extra shots and it's possible.
- 1:29:15Speaker 2: So can you imagine if I was prescribed a drug
- 1:29:19Speaker 2: for a patient and they took, I said, take one
- 1:29:21Speaker 2: pill a day. And they said, well, it's such a
- 1:29:23Speaker 2: good pill. I think I'll take 20 or I'll take
- 1:29:25Speaker 2: 50 or I'll take a hundred. Can you imagine me saying, well, sure,
- 1:29:27Speaker 2: just take as many as you want to. We would
- 1:29:30Speaker 2: never do this. And so with vaccines, there is a
- 1:29:34Speaker 2: delusional scheme that the more vaccines, the better.
- 1:29:40Speaker 1: But vaccines have been helpful throughout history. Sure.
- 1:29:44Speaker 2: So in our book, you know, vaccines, mythology, ideology, and reality,
- 1:29:48Speaker 2: there's a reality for sure. So the measles vaccine, that's
- 1:29:52Speaker 2: a good example. It definitely dropped the case count of measles.
- 1:29:57Speaker 2: But it's not perfect. So if you took the shot,
- 1:30:00Speaker 2: you still could get measles. So we have measles outbreaks.
- 1:30:04Speaker 2: And on top of that, there's like any drug, there's
- 1:30:08Speaker 2: always risks and benefits. So what's the risks of the
- 1:30:12Speaker 2: measles vaccine? This is important. This is another one that's
- 1:30:15Speaker 2: on the Zenodo server, you guys. We just came out
- 1:30:17Speaker 2: with this. We analyzed how many babies died after the
- 1:30:22Speaker 2: measles vaccine, the MMR vaccine, since the 1990s.
- 1:30:24Speaker 1: Answer?
- 1:30:27Speaker 2: I think there's over 100 kids, maybe 200 kids died.
- 1:30:30Speaker 1: From the vaccine.
- 1:30:31Speaker 2: It was a combination of vaccines, but they found them
- 1:30:33Speaker 2: dead in their bassinet. How many people died of measles
- 1:30:36Speaker 2: during that same time? About six or eight. You get
- 1:30:41Speaker 2: the exact numbers if you guys go on the server.
- 1:30:43Speaker 2: So there are risks. That's the point. Nothing is risk-free.
- 1:30:47Speaker 2: Let me give you another one.
- 1:30:48Speaker 1: But right there, what you're saying is, yeah, it's effective.
- 1:30:51Speaker 2: Yeah, it drops the case count, but you could lose
- 1:30:54Speaker 2: your baby with it.
- 1:30:55Speaker 1: Got it.
- 1:30:56Speaker 2: Okay. Now, what about chickenpox? I had chickenpox as a kid,
- 1:31:01Speaker 2: but my kids didn't get chickenpox. They took the shots.
- 1:31:05Speaker 2: So chickenpox lowers the case count. Terrific. But what's the catch?
- 1:31:11Speaker 2: There's always a catch. That's the point. The catch is
- 1:31:14Speaker 2: that now there's a higher rate of adult shingles if
- 1:31:18Speaker 2: you take the chickenpox vaccine.
- 1:31:20Speaker 1: So you're really just pushing it down the road then?
- 1:31:22Speaker 2: Well, it's a trade-off. It's a tradeoff.
- 1:31:25Speaker 1: Who doesn't want chickenpox? First of all, you get out
- 1:31:27Speaker 1: of school for like two or three days.
- 1:31:30Speaker 2: And you get permanent immunity. So there's always a tradeoff.
- 1:31:35Speaker 2: So there's an important paper in JAMA recently by Vesuvian, V-A-S-E-D-U-V-A-N.
- 1:31:45Speaker 2: That said, a large number of parents now are not
- 1:31:49Speaker 2: going to get their kids fully vaccinated. They've seen enough
- 1:31:51Speaker 2: of this now.
- 1:31:52Speaker 1: Is that alarming to you, or how does that look
- 1:31:54Speaker 1: to you?
- 1:31:54Speaker 2: Well, I think it's going to bring us back to
- 1:31:57Speaker 2: a more appropriate use of vaccines. Now, I'm not against
- 1:32:01Speaker 2: the use of vaccines. I took every vaccine known to
- 1:32:04Speaker 2: man except for the COVID shots. I've taken all kinds
- 1:32:07Speaker 2: of flu shots. My kids took all the vaccines, so
- 1:32:09Speaker 2: I'm not against vaccines. But I think they're excessively used.
- 1:32:13Speaker 2: And where we're going is what's called risk stratification. That is,
- 1:32:19Speaker 2: there has to be some meaningful risk of the disease
- 1:32:23Speaker 2: for you to take the shot. So let me give
- 1:32:26Speaker 2: an example. If you've had your spleen taken out, you
- 1:32:29Speaker 2: had a car accident, you got taken out or taken
- 1:32:31Speaker 2: out for other reasons, like my brother-in-law has been taken out.
- 1:32:34Speaker 2: You can die from a pneumococcal infection, meningococcal infection, or
- 1:32:39Speaker 2: haemophilus infection. It's called encapsulator organisms. I feel very strongly
- 1:32:44Speaker 2: if you've had your spleen taken out, you should get
- 1:32:45Speaker 2: those vaccines because it's compelling. It's like you don't have
- 1:32:49Speaker 2: a chance. I've seen some patients go down with these infections. However,
- 1:32:54Speaker 2: if you're young and healthy like you and I, I mean,
- 1:32:56Speaker 2: come on. I mean, you're not going to go down
- 1:33:00Speaker 2: with a pneumonia. It's just not going to happen. Let
- 1:33:04Speaker 2: me give another example. This came up recently. A healthy
- 1:33:07Speaker 2: baby born where the mother is negative for hepatitis B
- 1:33:12Speaker 2: The baby is fine. The baby has zero chance of
- 1:33:15Speaker 2: getting hepatitis B until they get into teenage years. And
- 1:33:18Speaker 2: even then, they're probably going to be fine. Depends on
- 1:33:20Speaker 2: what choices they make with IV drug abuse and sexual partners,
- 1:33:24Speaker 2: what have you. It's just not compelling to give them
- 1:33:27Speaker 2: the hepatitis B vaccine. Now, I took it myself when
- 1:33:31Speaker 2: I went into medical school and I was going to
- 1:33:34Speaker 2: work with blood and what have you or a paramedic
- 1:33:37Speaker 2: or a police officer. But not every person needs to
- 1:33:40Speaker 2: take the hepatitis B vaccine. I think it's compelling. The
- 1:33:43Speaker 2: highest risk for hepatitis B, transmitting it to the baby,
- 1:33:50Speaker 2: is in about 20,000 mothers who have active hep B.
- 1:33:54Speaker 2: Most of them are immigrants, by the way, from outside
- 1:33:56Speaker 2: the United States. They come here, they have hep B,
- 1:33:59Speaker 2: they're going to give it to the baby. And so
- 1:34:00Speaker 2: when that occurs, the mother gets the vaccine, the mother
- 1:34:03Speaker 2: gets a drug called Fosinovir, And the baby gets hepatitis
- 1:34:07Speaker 2: B immunoglobulin and the baby gets... So we have for 20,000
- 1:34:11Speaker 2: babies out of 3.3 million born, we have a good
- 1:34:15Speaker 2: hepatitis B transmission. It's very effective. It's 90% effective. But
- 1:34:20Speaker 2: it doesn't have to be applied to all 3.3 million.
- 1:34:23Speaker 1: Got it.
- 1:34:24Speaker 2: So recently, even Rand Paul said this. Others said that, listen,
- 1:34:27Speaker 2: we're overdoing vaccines. So I think where we're going is
- 1:34:31Speaker 2: risk stratification. One that's going to come up, you're going
- 1:34:34Speaker 2: to hear about it. is actually the human papillomavirus vaccine, HPV.
- 1:34:39Speaker 1: Yeah, I've heard about that.
- 1:34:40Speaker 2: Again, that's sexually transmitted, and it's given to all children
- 1:34:46Speaker 2: in teenage years. But I can tell you, you know
- 1:34:49Speaker 2: what the most compelling group is that transmits this virus
- 1:34:53Speaker 2: like you cannot believe? Gay and bisexual men. Anal intercourse, unprotected,
- 1:35:00Speaker 2: watch out, anal carcinoma, penile carcinoma, et cetera, and oral
- 1:35:04Speaker 2: head and neck cancers. So the bottom line is, you know,
- 1:35:08Speaker 2: HPV vaccine? Yeah, gay or bisexual man? For sure.
- 1:35:13Speaker 1: Everyone? Probably not. Everyone?
- 1:35:15Speaker 2: It's got to be an individual decision. So we have
- 1:35:19Speaker 2: to get to risk stratification and freedom of choice as
- 1:35:24Speaker 2: opposed to putting it on the government schedule and forcing
- 1:35:27Speaker 2: it into people.
- 1:35:28Speaker 1: The CDC recommends routine HPV vaccinations for preteens at 11
- 1:35:32Speaker 1: or 12 years old. but it can be started as
- 1:35:34Speaker 1: early as age nine with the goal of protecting them
- 1:35:36Speaker 1: before exposure to HPV as it works best at younger ages.
- 1:35:42Speaker 1: But here's one question I have. At a certain point,
- 1:35:45Speaker 1: wouldn't some of these drug companies or these, like if
- 1:35:49Speaker 1: there's bigger entities out there that are this cabal of control,
- 1:35:58Speaker 1: wouldn't they, is there more money in them you battling
- 1:36:02Speaker 1: these diseases over time than there is just in one vaccine?
- 1:36:04Speaker 1: You know what I'm saying? Like, wouldn't it then on
- 1:36:07Speaker 1: them tabulating how much money they could make off of
- 1:36:09Speaker 1: a person, wouldn't it be like, oh, well, it's better
- 1:36:12Speaker 1: if we have them battling these two diseases or instead
- 1:36:15Speaker 1: of getting a vaccine early. Does that make sense?
- 1:36:17Speaker 2: No, the question is good. If you're a drug company
- 1:36:21Speaker 2: and you say, I've got two choices. I'm going to
- 1:36:24Speaker 2: make a vaccine or I'm going to make a drug
- 1:36:27Speaker 2: to treat the disease. You would take the vaccine every
- 1:36:30Speaker 2: time because the vaccine, let's say a universal vaccine like influenza,
- 1:36:38Speaker 2: you're going to give it to 300 million people. That's
- 1:36:42Speaker 2: 300 million doses.
- 1:36:44Speaker 1: Got it.
- 1:36:45Speaker 2: If you get influenza and severe influenza, you'd have a
- 1:36:48Speaker 2: drug that's maybe given to 50,000 people. It's night and day.
- 1:36:53Speaker 1: So then right there, that should be information to us
- 1:36:55Speaker 1: that that makes– like it makes more sense than if
- 1:36:59Speaker 1: you're like, well, let me just wait and see what 50,000
- 1:37:01Speaker 1: people would have these symptoms or get this, it feels like.
- 1:37:05Speaker 2: From a public health perspective, my view on this is
- 1:37:08Speaker 2: that it should all be about treatment, right? I mean,
- 1:37:11Speaker 2: so have you ever gotten influenza test positive ever? You've
- 1:37:18Speaker 2: never even gotten it or tested for it?
- 1:37:20Speaker 1: I don't have it.
- 1:37:22Speaker 2: Okay, you never have.
- 1:37:22Speaker 1: Never have.
- 1:37:23Speaker 2: Have you ever taken an influenza vaccine?
- 1:37:26Speaker 1: I don't know.
- 1:37:27Speaker 2: I can tell you, that shows you. It's completely irrelevant
- 1:37:30Speaker 2: to you. I've never had influenza and I've never taken
- 1:37:33Speaker 2: the test.
- 1:37:33Speaker 1: I've never even met anybody that's even said it before. Right.
- 1:37:36Speaker 2: So my point is, why is it recommended for you, me,
- 1:37:41Speaker 2: every human being on earth, including little babies, every year?
- 1:37:45Speaker 1: But is the reason why we're not talking about it
- 1:37:47Speaker 1: or anything or know anybody that has it because of it?
- 1:37:50Speaker 2: Well, you don't take the shots.
- 1:37:52Speaker 1: Oh, that's right. But did I once get it when
- 1:37:54Speaker 1: I was a child?
- 1:37:54Speaker 2: No, what I'm saying is it's an annual risk.
- 1:37:57Speaker 1: Oh, I didn't know that.
- 1:37:57Speaker 2: Do you see what I mean? So it's an annual risk.
- 1:37:59Speaker 2: So the point is the fear of infectious diseases is
- 1:38:04Speaker 2: grossly exaggerated to promote vaccine uptake. Vaccine mythology and ideology
- 1:38:12Speaker 2: has been going on for 300 years. This is medical religion.
- 1:38:16Speaker 2: This is medical. Do you know some doctors will throw
- 1:38:19Speaker 2: a patient out of their office if they don't take
- 1:38:20Speaker 2: a vaccine? Yeah, pediatricians will. They'll say, listen, if your
- 1:38:25Speaker 2: kid doesn't take a vaccine, they're out of here.
- 1:38:27Speaker 1: Oh yeah, I've seen people fighting about that online. Like,
- 1:38:30Speaker 1: you know, I didn't want my kids to have the
- 1:38:32Speaker 1: vaccines and this is how they treated us.
- 1:38:35Speaker 2: Can you imagine, I prescribe blood pressure medicines. If you
- 1:38:38Speaker 2: don't take this blood pressure medicine, I'm throwing you out
- 1:38:41Speaker 2: of my office.
- 1:38:42Speaker 1: Yeah.
- 1:38:42Speaker 2: I mean, this is, it's insane. It's a religion and
- 1:38:47Speaker 2: how the ideology works is like this, that there's always
- 1:38:51Speaker 2: been historically tremendous fear of infectious diseases and that we're vulnerable.
- 1:38:57Speaker 2: We're vulnerable. But through the brilliance of man, man and
- 1:39:03Speaker 2: vaccines can improve upon God's creation. Man outdoes God with vaccines.
- 1:39:12Speaker 2: This is very important. And because the vaccines aren't perfect,
- 1:39:19Speaker 2: We all have to take them. And because this is
- 1:39:22Speaker 2: such a laudable goal for humanity, if some people are
- 1:39:26Speaker 2: injured or disabled or died of the vaccine, they should
- 1:39:30Speaker 2: take it for the betterment of humanity. They should take
- 1:39:33Speaker 2: it for the team. It's collateral damage and it's acceptable
- 1:39:37Speaker 2: in the eyes of this vaccine ideology. It is a
- 1:39:42Speaker 2: runaway freight train. Look at the front of our book.
- 1:39:45Speaker 2: Look at the coin on the front of the book.
- 1:39:46Speaker 2: Look at the iconography. That's a boy. This is a
- 1:39:50Speaker 2: 22 euro coin issued by the Vatican. That's a boy
- 1:39:55Speaker 2: in the tripartite imagery.
- 1:39:56Speaker 1: Oh, there's a boy getting a vaccine. This coin was
- 1:39:59Speaker 1: issued by the Vatican?
- 1:39:59Speaker 2: Yeah, issued by the Vatican. But look at this. This
- 1:40:02Speaker 2: is during the pandemic. The boy... should be receiving the Eucharist.
- 1:40:07Speaker 2: He should be receiving the body and blood of Jesus Christ.
- 1:40:11Speaker 1: But instead, he's receiving the vaccine. Yes. So you're saying
- 1:40:14Speaker 1: there's a bigger psychology here of playing God.
- 1:40:18Speaker 2: It's a religion. The point is, it's a religion. That's
- 1:40:21Speaker 2: the reason why people can't talk about it. That's the
- 1:40:23Speaker 2: reason why doctors are nuts over this. That's the reason
- 1:40:26Speaker 2: why there are no lectures about side effects from vaccines.
- 1:40:30Speaker 1: No grand rounds.
- 1:40:31Speaker 2: No grand rounds. We can't talk about it. There are
- 1:40:34Speaker 2: people listening to your show. They still can't talk to
- 1:40:38Speaker 2: their relatives about this.
- 1:40:41Speaker 1: Well, now everyone's in a spot where it's like it
- 1:40:44Speaker 1: feels like a lot of people know that it's bullshit,
- 1:40:48Speaker 1: but you don't want to bring it up to people
- 1:40:49Speaker 1: because they've probably had the vaccine and you don't want
- 1:40:52Speaker 1: to hurt somebody's feelings.
- 1:40:53Speaker 2: What did I do when I came here? I did
- 1:40:55Speaker 2: a quick check. Did everybody take the vaccine? Where are
- 1:40:57Speaker 2: we on this? Because people start to get pretty uncomfortable
- 1:41:00Speaker 2: when we talk about this.
- 1:41:02Speaker 1: Yeah. If you have something swimming in your pool and
- 1:41:04Speaker 1: you don't want to admit it but you don't have
- 1:41:06Speaker 1: a net, then what– you know what I'm saying? Like
- 1:41:08Speaker 1: it's a little bit alarming because you can't– it's.
- 1:41:10Speaker 2: Going to be in there. That's the reason why I
- 1:41:12Speaker 2: have– you have the one doctor in the chair right
- 1:41:16Speaker 2: now where I was the first to devise– a method
- 1:41:20Speaker 2: to treat COVID patients to avoid hospitalization and death, McCullough Protocol,
- 1:41:24Speaker 2: the most widely used early treatment protocol in the world.
- 1:41:27Speaker 2: It's been credited with saving tens of millions of lives.
- 1:41:31Speaker 2: Sparing hundreds of millions of hospitalizations. Listen, Harvard could have
- 1:41:34Speaker 2: grabbed this. They didn't.
- 1:41:35Speaker 1: I did.
- 1:41:37Speaker 2: And now I've devised the first detoxification protocol.
- 1:41:40Speaker 1: I want to hear about it.
- 1:41:41Speaker 2: Of what people should do when they've had the infection
- 1:41:44Speaker 2: multiple times or they've taken a vaccine.
- 1:41:47Speaker 1: Now, does it only have to be they only took
- 1:41:49Speaker 1: one vaccine or do they have to get at least
- 1:41:50Speaker 1: two vaccines?
- 1:41:51Speaker 2: Listen, whether you take the infection, whether you've had the
- 1:41:54Speaker 2: infection or you've taken the vaccine, you've gotten the spike
- 1:41:58Speaker 2: protein in you. So it matters for virtually everybody.
- 1:42:00Speaker 1: So even if I never took the vaccine but I
- 1:42:03Speaker 1: tested that I had antibodies? Yeah.
- 1:42:06Speaker 3: Okay.
- 1:42:06Speaker 2: You've had some spike protein in you. Got it. So
- 1:42:08Speaker 2: we've been studying this. This is McCullough Protocol-based spike protein detoxification,
- 1:42:12Speaker 2: first published in 2023, peer-reviewed literature. And after working with
- 1:42:18Speaker 2: every drug under the sun, the Biden administration spent a
- 1:42:21Speaker 2: billion dollars on this. They found no drugs. Turns out
- 1:42:24Speaker 2: three natural products have a huge impact, natokinase, bromelain, and curcumin.
- 1:42:30Speaker 2: Natokinase and bromelain are natural products. Now, we use them
- 1:42:33Speaker 2: in high doses, medicinal doses, but they dissolve the spike
- 1:42:37Speaker 2: protein in the body. They help you clear it out.
- 1:42:40Speaker 2: Curcumin is blocking the inflammatory effects of the spike protein,
- 1:42:44Speaker 2: and they're well-tolerated in high doses. Remember, most prescription drugs
- 1:42:48Speaker 2: are still natural products. They're just in high doses. And
- 1:42:51Speaker 2: so this protocol was published. And then now we've published
- 1:42:56Speaker 2: multiple cases. And I've experienced in thousands of patients, we
- 1:42:59Speaker 2: reliably bring antibodies to the spike protein down. And when
- 1:43:03Speaker 2: we can measure spike protein directly, that's coming down and
- 1:43:07Speaker 2: patients get better. It takes a long time. So it
- 1:43:11Speaker 2: takes probably over a year to have taken the supplements.
- 1:43:14Speaker 1: And how often should they take them? Is that it
- 1:43:16Speaker 1: right there?
- 1:43:17Speaker 2: This is it. So this is the lead product. This
- 1:43:19Speaker 2: is from the wellness company, the Ultimate Spike Detox. And
- 1:43:24Speaker 2: this is high-dose natokinase, bromelain, and curcumin. We formed a
- 1:43:28Speaker 2: whole company around this. Well, this company is probably one
- 1:43:30Speaker 2: of the greatest success stories out of the pandemic. It's
- 1:43:34Speaker 2: now a global healthcare company. telemedicine, nutraceuticals and supplements, emergency kits.
- 1:43:40Speaker 2: We'll never get burned again because now we have treatment
- 1:43:42Speaker 2: kits for pandemics. And I've told people, listen, I don't
- 1:43:45Speaker 2: think the government's going to save us from the next pandemic,
- 1:43:47Speaker 2: but the wellness company will. And we continue to innovate.
- 1:43:51Speaker 2: People need, in general, they need over a year of
- 1:43:55Speaker 2: this to clear this spike protein out. Take a look
- 1:43:58Speaker 2: at it.
- 1:43:58Speaker 1: How do you decide what supplements are safe and effective
- 1:44:00Speaker 1: enough to put in here and what grades?
- 1:44:02Speaker 2: Well, we have a medical board. We had certainly multiple meetings.
- 1:44:05Speaker 2: We went through dose ranging. Once we got to the product,
- 1:44:08Speaker 2: we had to go through the Federal Trade Commission.
- 1:44:10Speaker 1: So this isn't just some white-labeled thing.
- 1:44:12Speaker 2: No, no. This is the real deal. And so it's
- 1:44:15Speaker 2: all science-backed. And we intentionally did not patent this. It's
- 1:44:23Speaker 2: copyrighted mainly for just accountability. But we did not patent
- 1:44:26Speaker 2: it because so many people worldwide need it. Now have fun.
- 1:44:30Speaker 2: Are you on Amazon? Go to Amazon and type in
- 1:44:33Speaker 2: Spike Detox. I did this before I came. There are
- 1:44:37Speaker 2: dozens and dozens of products. There are dozens. Type in
- 1:44:41Speaker 2: spike detox.
- 1:44:42Speaker 1: Are there any side effects of it? Yeah.
- 1:44:45Speaker 2: So if you look, most of it is ours, but
- 1:44:47Speaker 2: you'll just scroll down. You'll see a zillion different products.
- 1:44:49Speaker 2: So the bottom line is this tells you people know
- 1:44:53Speaker 2: about the spike protein. All this wouldn't be on Amazon.
- 1:44:57Speaker 1: I agree.
- 1:44:57Speaker 2: Now, listen, the doctors are not measuring this in the bloodstream.
- 1:45:00Speaker 2: The doctors are not talking about spike protein. It's not
- 1:45:04Speaker 2: in New England Journal of Medicine or JAMA, but it's
- 1:45:06Speaker 2: all over Amazon. That should tell you something. It's absolutely hilarious.
- 1:45:11Speaker 1: Or that there's a fear of it out there and
- 1:45:13Speaker 1: people are capitalizing on a fear. Yeah.
- 1:45:16Speaker 2: You know, that's a fair point.
- 1:45:18Speaker 1: I mean, it could be.
- 1:45:20Speaker 2: That's a fair point.
- 1:45:20Speaker 1: Because I've looked at hair medicine, like hair scalp things
- 1:45:23Speaker 1: over the years on that you find articles like this.
- 1:45:25Speaker 1: This will help. And they set you up with an article.
- 1:45:27Speaker 1: And then like, even if you don't even go on
- 1:45:30Speaker 1: the link from the article to the product, but then
- 1:45:32Speaker 1: you go find their product, and then you realize, and
- 1:45:35Speaker 1: then I've had things come out like this thing doesn't
- 1:45:37Speaker 1: do anything. It was just a, it was funny.
- 1:45:38Speaker 2: But here's the thing. Natokinase is used by the Japanese
- 1:45:44Speaker 2: as a heart supplement.
- 1:45:45Speaker 1: Oh, I love them.
- 1:45:46Speaker 2: Because it helps unblock arteries. So natokinase is beneficial anyway.
- 1:45:52Speaker 2: Bromelain- is derived from pineapple. It's also anti-infective and healthy.
- 1:45:58Speaker 2: Bromelain is actually used as a prescription drug in a
- 1:46:02Speaker 2: form of an ointment that's used in deep burn wounds.
- 1:46:06Speaker 2: And then curcumin is derived from turmeric. That's anti-arthritic. That's
- 1:46:10Speaker 2: a healthy supplement. So bottom line is, you know, no
- 1:46:14Speaker 2: one's capitalizing because these are three healthy supplements anyway, but
- 1:46:18Speaker 2: we have a compelling case to use them in spike detoxification.
- 1:46:22Speaker 1: How were you able to test that it worked?
- 1:46:24Speaker 2: Well, this is perfect for HHS, Robert F. Kennedy and
- 1:46:29Speaker 2: his team to do a large prospective double-blind randomized placebo-controlled trial.
- 1:46:34Speaker 1: Have they done it yet? No.
- 1:46:36Speaker 2: Have they even called about it?
- 1:46:38Speaker 1: No.
- 1:46:38Speaker 2: No. What would that trial mean? I would mean 20,000
- 1:46:42Speaker 2: people in each group. It would probably be a $ 50
- 1:46:43Speaker 2: million trial, $ 100 million trial. For sure, it should be done.
- 1:46:47Speaker 1: I'll be a guinea pig.
- 1:46:48Speaker 2: This is it. So this is ready to go. A
- 1:46:51Speaker 2: lot of people, as you can tell by Amazon, people
- 1:46:53Speaker 2: don't want to wait. If our government hasn't even started
- 1:46:56Speaker 2: thinking about testing it, people don't want to wait. They're
- 1:46:59Speaker 2: doing it.
- 1:47:00Speaker 1: All government's a pack of shit.
- 1:47:01Speaker 2: Now, remember, anything that actually works has side effects. You
- 1:47:04Speaker 2: asked the question. This is a form of a blood thinner.
- 1:47:09Speaker 2: So people can have more easy bruising. I just told
- 1:47:12Speaker 2: somebody on the way here, you know, if they start
- 1:47:14Speaker 2: to get nose bleeding or bleeding when they brush their teeth.
- 1:47:16Speaker 1: Whoa.
- 1:47:17Speaker 2: No, yeah. So it's a natural product, but it's a
- 1:47:21Speaker 2: blood thinner. The spike protein causes blood clotting. So we
- 1:47:25Speaker 2: have an epidemic of blood clotting. So everybody is prone
- 1:47:28Speaker 2: to this. I personally took it, take it, I took
- 1:47:31Speaker 2: it this morning, take it on an empty stomach. And,
- 1:47:33Speaker 2: you know, I had measured my spike antibodies and my
- 1:47:36Speaker 2: spike antibodies, which should be zero, but since I had
- 1:47:41Speaker 2: COVID at least once proven and probably two other times,
- 1:47:44Speaker 2: my spike antibodies were 2,300. And the published literature suggests
- 1:47:49Speaker 2: under a thousand, you're probably safe. You probably cleared it out,
- 1:47:51Speaker 2: just residual antibodies. I was 2,300. My ears are ringing.
- 1:47:55Speaker 2: I didn't feel well. I went on spike detox. It
- 1:47:57Speaker 2: took about a year. but I've dropped it to 900. Amen.
- 1:48:00Speaker 1: Let's go.
- 1:48:00Speaker 2: Now, the average person who's had taken a vaccine, who's
- 1:48:03Speaker 2: got a trouble, blood clot, heart damage, they're at 11,000.
- 1:48:07Speaker 2: And we commonly see people over 25,000. So people who
- 1:48:11Speaker 2: are in trouble.
- 1:48:12Speaker 1: How can people get checked to see what they're at
- 1:48:14Speaker 1: to know if it's- Blood.
- 1:48:14Speaker 2: Test, super important. Let's go to LabCorp. You can self-order
- 1:48:18Speaker 2: your blood test. You should do it.
- 1:48:20Speaker 1: Yeah. I'm getting some blood work done this week, actually.
- 1:48:22Speaker 2: You should do it. Go to LabCorp.
- 1:48:24Speaker 1: Okay.
- 1:48:24Speaker 2: So now go to individuals and patients. So go to
- 1:48:31Speaker 2: more on-demand tests.
- 1:48:32Speaker 1: There we go.
- 1:48:34Speaker 2: And it's going to be a COVID antibody test. Keep going.
- 1:48:38Speaker 1: There we go.
- 1:48:39Speaker 2: There, click on this. This is the test. It's 69. Okay,
- 1:48:41Speaker 2: stop here. If you get a user ID and password
- 1:48:44Speaker 2: right here and you pay $ 69, you use your credit card,
- 1:48:47Speaker 2: you pay right here, then the order's at LabCorp. You
- 1:48:51Speaker 2: can go in there, get your blood test, and you'll
- 1:48:54Speaker 2: know that night your number. If you're under 1,000, you're safe.
- 1:48:58Speaker 1: Okay.
- 1:48:59Speaker 2: If you're above 5,000, you probably got the spike protein
- 1:49:02Speaker 2: in your bloodstream. And if you're over 10,000 or above,
- 1:49:05Speaker 2: you're in trouble. Yeah. And there's about a correlation of
- 1:49:09Speaker 2: about 0.8 to 0.9 of the antibody to the actual
- 1:49:12Speaker 2: spike protein. Soon there's going to be a direct spike
- 1:49:14Speaker 2: protein test. And we're working hard with companies to do that.
- 1:49:18Speaker 2: But this is a super useful test. Do you know
- 1:49:20Speaker 2: that the Mayo Clinic refuses to order this test?
- 1:49:23Speaker 1: Wow.
- 1:49:23Speaker 2: And so does every other major hospital. If you go
- 1:49:25Speaker 2: in and you say, doctor, I want a COVID test.
- 1:49:27Speaker 2: I want to assess my spike exposure. They'll say, I
- 1:49:29Speaker 2: refuse to do it. So LabCorp got so frustrated. They
- 1:49:33Speaker 2: just offer this to the public and say, pay 69 bucks.
- 1:49:36Speaker 2: You can self-order your COVID test.
- 1:49:38Speaker 1: Good for them.
- 1:49:39Speaker 2: We've published a whole spike guide on this, how to
- 1:49:41Speaker 2: interpret it. And so like I told you, the average
- 1:49:45Speaker 2: person who took the shot who's in trouble in a
- 1:49:48Speaker 2: paper by Barham and colleagues is 11,000. So my mother-in-law,
- 1:49:53Speaker 2: who's now 93, she lives with us. She took two
- 1:49:55Speaker 2: Pfizer shots because we had to get her out of Canada.
- 1:49:58Speaker 2: She was older and pandemic and what have you. She's
- 1:50:02Speaker 2: never had a side effect once. No sore arm, nothing.
- 1:50:05Speaker 2: She goes, I don't know what you're making such a
- 1:50:07Speaker 2: big deal about these COVID shots.
- 1:50:09Speaker 1: Nothing.
- 1:50:09Speaker 2: And I've been watching her carefully. I'm telling you, she
- 1:50:11Speaker 2: has nothing wrong with her from the COVID shots. I said,
- 1:50:14Speaker 2: I can't believe this. So, and I told you, I
- 1:50:17Speaker 2: was 2,300. I didn't take the shots, but I had
- 1:50:19Speaker 2: the illness. So we checked mama, you know what she was? 200.
- 1:50:22Speaker 2: No wonder she's fine. So the point is, there's probably
- 1:50:28Speaker 2: easily 85% of people who took the shots They got
- 1:50:32Speaker 2: basically a dud. They got next to nothing.
- 1:50:34Speaker 1: Got it.
- 1:50:34Speaker 2: They have no antibodies. They never got much exposure to
- 1:50:37Speaker 2: spike and they're fine.
- 1:50:38Speaker 1: The reading that you're looking for, the number that you're
- 1:50:40Speaker 1: looking for coming back, it's what? Spike proteins?
- 1:50:42Speaker 2: It's actually the antibody to the spike protein.
- 1:50:43Speaker 1: Okay. So you're looking for the antibody number to the
- 1:50:45Speaker 1: spike protein. Which is- If you're under 1,000- 1,000. Then
- 1:50:48Speaker 1: you're doing fine.
- 1:50:49Speaker 2: Yeah.
- 1:50:49Speaker 1: If you're 5,000 or up, then you should get checked out.
- 1:50:51Speaker 2: Yeah, you need to get going. Well, you need to
- 1:50:53Speaker 2: get going. You need to get going on, at least
- 1:50:55Speaker 2: on the ultimate spike detox.
- 1:50:56Speaker 1: Got it.
- 1:50:57Speaker 2: And- You know, once starting, I've treated thousands of patients. Now,
- 1:51:02Speaker 2: I do have to prescribe some drugs in addition for
- 1:51:04Speaker 2: certain syndromes. Now, what does that mean? Well, what I
- 1:51:07Speaker 2: mean is if there's heart damage, there's another drug I
- 1:51:09Speaker 2: have to prescribe called colchicine.
- 1:51:11Speaker 1: Okay. How do people know if there's heart damage?
- 1:51:13Speaker 2: Well, I've published kind of the leading paper on this
- 1:51:19Speaker 2: called Risk Stratification. But in general, it's prompted by symptoms,
- 1:51:23Speaker 2: EKG and an ultrasound. I just do that in my office.
- 1:51:27Speaker 1: Got it.
- 1:51:27Speaker 2: Any standard doctor would do that. But the point is
- 1:51:32Speaker 2: some people additionally need prescription drugs. But once people are
- 1:51:35Speaker 2: on the detoxification program, and I think I'm the most
- 1:51:39Speaker 2: experienced doctor in the world in treating patients with this condition,
- 1:51:43Speaker 2: I've never seen a new blood clot. I've never seen
- 1:51:45Speaker 2: a cardiac arrest. I've never seen a new problem emerge.
- 1:51:50Speaker 1: Amen.
- 1:51:50Speaker 2: All the people... who are emerging with problems now. Oh,
- 1:51:54Speaker 2: I got a blood clot now. Oh, I've got an
- 1:51:57Speaker 2: advanced cancer now. Oh, I've got some, they have not
- 1:52:00Speaker 2: done the detox.
- 1:52:01Speaker 1: Got it.
- 1:52:02Speaker 2: So important. It's probably the biggest public health message I
- 1:52:05Speaker 2: can give on this show is, you know, if you
- 1:52:08Speaker 2: just want to play it safe and want some healthy
- 1:52:10Speaker 2: supplements anyway, a lot of people take supplements, they just
- 1:52:12Speaker 2: take it empirically.
- 1:52:13Speaker 1: Take it for a year.
- 1:52:15Speaker 2: And at least a year, And extended use if you
- 1:52:18Speaker 2: have underlying heart disease or risk for blood clots or elsewhere.
- 1:52:21Speaker 1: How many a day?
- 1:52:23Speaker 2: Two capsules twice a day, empty stomach.
- 1:52:25Speaker 1: Okay.
- 1:52:26Speaker 2: Best time to take it, I think, is if you
- 1:52:27Speaker 2: get up at night to use the restroom and your
- 1:52:29Speaker 2: stomach's empty, take it with some water before you go
- 1:52:31Speaker 2: back to bed and just take it on an empty stomach.
- 1:52:33Speaker 1: Got it.
- 1:52:34Speaker 2: I saw a woman yesterday who has a rare genetic condition.
- 1:52:39Speaker 2: But it impairs the nerves. What is it?
- 1:52:41Speaker 1: She was good at parallel parking? That's just an old joke?
- 1:52:44Speaker 2: No, she's actually very bright. She's very successful in her job.
- 1:52:48Speaker 2: She comes in. But her genetic condition, the nerves don't
- 1:52:53Speaker 2: allow the capillaries to open and close correctly. And so
- 1:52:57Speaker 2: she's modeled all over with a pattern called levito reticularis.
- 1:53:00Speaker 2: Doctors and nurses know what I'm talking about. And I
- 1:53:04Speaker 2: saw her walking down the hall because I was getting
- 1:53:06Speaker 2: ready to you know, have her and her husband come
- 1:53:08Speaker 2: in the office. And I just, she just looked so.
- 1:53:12Speaker 1: Ill.
- 1:53:12Speaker 2: She looked chronically ill. She's 20 years younger than me.
- 1:53:15Speaker 2: And she said, doctor, I have this genetic condition. And
- 1:53:20Speaker 2: when I took the vaccine, it absolutely ravaged me. And
- 1:53:26Speaker 2: I have intractable headaches. Look at me. She looked so terrible.
- 1:53:31Speaker 2: The condition is actually called Mitchell's disease, if you'll type
- 1:53:34Speaker 2: in Mitchell's disease. So the point is, but listen to this.
- 1:53:40Speaker 2: When she walked in my office, I did not know
- 1:53:42Speaker 2: what Mitchell's disease was. She came in, I have Mitchell's disease.
- 1:53:46Speaker 2: So what did I do? A smart doctor. I get
- 1:53:50Speaker 2: to a certain point where I said, listen, I have
- 1:53:52Speaker 2: to have you change into a gown because I'm going
- 1:53:54Speaker 2: to get an EKG. While she's changing into the gown,
- 1:53:57Speaker 2: I go on artificial intelligence, and I look up Mitchell's disease.
- 1:54:01Speaker 2: In two seconds, I have the answer. In fact, I
- 1:54:04Speaker 2: even have the genetic mutation for Mitchell's disease now known,
- 1:54:08Speaker 2: which is an SCN9A mutation. And I came back in
- 1:54:11Speaker 2: the office, and I do the next part. I said,
- 1:54:14Speaker 2: so you have this rare disease. It's a mutation of
- 1:54:17Speaker 2: the SCN9A gene that gates a voltage into these nerves.
- 1:54:23Speaker 2: She goes, you're the first doctor who's ever seen it.
- 1:54:26Speaker 2: identify that. And I said, you know, it's just, but
- 1:54:29Speaker 2: the point I'm making is that's the power of artificial intelligence.
- 1:54:33Speaker 2: I could have gotten to it. It would have taken forever.
- 1:54:35Speaker 1: For sure.
- 1:54:36Speaker 2: And I got to it. In fact, before I finished,
- 1:54:40Speaker 2: I ordered the correct genetic test on her, which she's
- 1:54:42Speaker 2: never had before, got her on spike detoxification, ordered the
- 1:54:46Speaker 2: other appropriate labs. And she literally hugged me. She goes,
- 1:54:49Speaker 2: I have never had anybody even pay any attention to me.
- 1:54:54Speaker 2: I'm absolutely miserable at this. And now I can see
- 1:54:56Speaker 2: a pathway out of this.
- 1:54:58Speaker 1: That's the biggest thing. People want to, yeah, they just
- 1:55:00Speaker 1: want you to hear what's going on with them a
- 1:55:01Speaker 1: lot of times. A couple of questions I got to
- 1:55:03Speaker 1: get answers to just so we, RFK has been in
- 1:55:06Speaker 1: office for over a year now, right? As Secretary of
- 1:55:09Speaker 1: Health and Human Services. How do you feel like he's
- 1:55:12Speaker 1: done there?
- 1:55:13Speaker 2: Well, you know, he's a friend. What I'd say is this,
- 1:55:17Speaker 2: is that if we've learned anything, you mentioned trust is
- 1:55:20Speaker 2: low in the government. The government doesn't treat patients. The
- 1:55:26Speaker 2: government's honestly not our caretaker. They're not our doctor. And
- 1:55:31Speaker 2: you probably never asked the question, how is Alex Azar doing?
- 1:55:34Speaker 2: You probably know who he was. He was HHS secretary
- 1:55:37Speaker 2: under Trump. Or how did Beshara do? He was HHS
- 1:55:41Speaker 2: secretary under Biden. You probably never asked that. The only
- 1:55:44Speaker 2: reason why you'd ask about RFK is because you know
- 1:55:47Speaker 2: him and he kind of has a celebrity status. let
- 1:55:50Speaker 2: me just say constructively what I would do if I
- 1:55:53Speaker 2: was in his job. I think that's probably a better
- 1:55:56Speaker 2: thing to say.
- 1:55:57Speaker 1: Yeah, I'm not trying to pitch you like saying something
- 1:55:59Speaker 1: negative about him.
- 1:56:00Speaker 2: No, but I'll just tell you what I would do. Now,
- 1:56:02Speaker 2: the difference is I'm a doctor with medical authority.
- 1:56:05Speaker 1: Right.
- 1:56:05Speaker 2: That's very different. There's nobody in Washington who has medical authority.
- 1:56:08Speaker 2: There's nobody in Washington that's ever treated a COVID patient,
- 1:56:12Speaker 2: that's ever had an important publication on COVID, ever innovated
- 1:56:15Speaker 2: with– a treatment protocol or detoxification. There's no one in
- 1:56:19Speaker 2: Washington with medical authority. Medical authority means I am taking
- 1:56:24Speaker 2: charge and I will handle this medical problem. No one.
- 1:56:28Speaker 2: So if I went to Washington, I would be the
- 1:56:30Speaker 2: only one with medical authority. So what would I do
- 1:56:32Speaker 2: on day one? I would have pulled the COVID vaccines
- 1:56:34Speaker 2: off the market. Just pulled them. Say, sorry, I have
- 1:56:38Speaker 2: medical authority. They're not safe. They're gone. It just, that's
- 1:56:44Speaker 2: what it is. It's the call. You just make the call.
- 1:56:48Speaker 2: It's not a political issue. This is a drug safety issue.
- 1:56:52Speaker 2: So I pull the COVID vaccines off the market. The
- 1:56:54Speaker 2: next thing I do is I use the power of
- 1:56:57Speaker 2: HHS and the office to do some very important things.
- 1:57:02Speaker 2: Virtually every major medical center and medical school gets funding
- 1:57:07Speaker 2: from HHS, not only through CMS for medical care, but
- 1:57:10Speaker 2: also from the National Institutes of Health and sometimes the CDC.
- 1:57:14Speaker 2: Every week I'd be having meetings in Washington saying there's
- 1:57:17Speaker 2: a mandatory meeting. Send your dean or your chief medical officer,
- 1:57:21Speaker 2: your chief of medicine, whatever, to Washington, and we're going
- 1:57:24Speaker 2: to have a review of lessons learned in the pandemic.
- 1:57:28Speaker 2: Which hospital had the best treatment protocols? Which one didn't?
- 1:57:31Speaker 2: Which had the lowest mortality? Which didn't? Vaccine safety. This
- 1:57:35Speaker 2: is what we're seeing with the vaccines. It's the reason
- 1:57:36Speaker 2: why we're pulling them off the market. In fact, you
- 1:57:38Speaker 2: could actually call rapid meetings. And say, listen, we're going
- 1:57:41Speaker 2: to go over the data, and we want to gain
- 1:57:43Speaker 2: a consensus. Before we tell the public we're pulling them
- 1:57:45Speaker 2: off the market, we want to make sure you got
- 1:57:47Speaker 2: your buy-in on this. And use the power of the
- 1:57:50Speaker 2: meeting to, you know, when you call a meeting, and
- 1:57:55Speaker 2: they happen all the time. They're called Bethesda meetings. In
- 1:57:58Speaker 2: the last two administrations, they literally haven't had any. But
- 1:58:01Speaker 2: we go to Washington. You have all kinds of experts
- 1:58:04Speaker 2: from academia, from the FDA, CDC, NIH, industry. You have
- 1:58:09Speaker 2: public citizens. There's an agenda. You raise some issues. You
- 1:58:14Speaker 2: basically vet them, gain a consensus, drive policy. That's the process.
- 1:58:21Speaker 2: So I'd be doing this every week. When it came
- 1:58:24Speaker 2: to diet, for sure I would have done that. I
- 1:58:30Speaker 2: And what I would do in that office is I
- 1:58:33Speaker 2: would get the medical orthodoxy on my side. I wouldn't
- 1:58:37Speaker 2: write policy with just a handful of assistants because there's
- 1:58:41Speaker 2: a million doctors out there. There's a half a million
- 1:58:43Speaker 2: nurse practitioners and PAs. There's 5,600 hospitals, 2,200 acute care hospitals.
- 1:58:49Speaker 2: I mean, come on. The medical industry is too big
- 1:58:52Speaker 2: and it's too strong. You can't do anything in Washington
- 1:58:55Speaker 2: without the medical community. That's what I would do. And
- 1:58:57Speaker 2: you can make it mandatory. So listen- If you want
- 1:58:59Speaker 2: to get your CMS funding, your NIH funding, you better
- 1:59:02Speaker 2: show up here. And I would do it for topic
- 1:59:05Speaker 2: after topic. Food dyes, fluoride. I'd go through childhood vaccines.
- 1:59:11Speaker 2: I'd go through the whole thing and just use Washington
- 1:59:14Speaker 2: as a convening and talk about make America healthy again.
- 1:59:18Speaker 2: If we had somebody with that type of leadership skills
- 1:59:20Speaker 2: and that type of vision, oh my gosh, healthcare in
- 1:59:23Speaker 2: the United States could be dramatically turned around.
- 1:59:27Speaker 1: Um, Do you think that the lobbies that are there
- 1:59:30Speaker 1: now and the big pharma and the cabal that's out
- 1:59:33Speaker 1: there now, do you think it, what's its end goal
- 1:59:37Speaker 1: for us? Does it, do you feel like?
- 1:59:40Speaker 2: Well, you know, in our first book, we outlined this
- 1:59:43Speaker 2: biopharmaceutical complex. It's powerful and it has the medical societies
- 1:59:49Speaker 2: with it. Remember I mentioned the smoke fest and this
- 1:59:54Speaker 2: great problem with smoking among doctors. Do you know the
- 1:59:57Speaker 2: American Medical Association was fully on board with smoking? They
- 2:00:01Speaker 2: were getting tobacco lobby money. And it wasn't until 1978
- 2:00:06Speaker 2: before they have the first pamphlet come out on this. Wow.
- 2:00:10Speaker 2: You know, 28 years after the evidence shows cancer, smoking
- 2:00:13Speaker 2: causes lung cancer.
- 2:00:14Speaker 1: After everybody made a buck, huh? Yeah.
- 2:00:17Speaker 2: So here, let's just take vaccines as an example. Well,
- 2:00:22Speaker 2: you've got the American College of Pediatrics. You've got the
- 2:00:24Speaker 2: American College of Obstetrics and Gynecology, American Medical Association. I mean,
- 2:00:28Speaker 2: this is a freight train. They all are fully in
- 2:00:32Speaker 2: lockstep on these vaccines. And so the lobby is very tight.
- 2:00:39Speaker 2: And they're told, I guarantee, non-physicians in Washington are told,
- 2:00:44Speaker 2: don't you flinch on these vaccines. If you do, polio
- 2:00:48Speaker 2: is coming back. And it's going to be on you.
- 2:00:51Speaker 1: Well, I'll tell you a story. This is one reason
- 2:00:53Speaker 1: why this stuff has always been interesting to me is
- 2:00:56Speaker 1: because I grew up in a community where Tulane University,
- 2:00:59Speaker 1: they had their primate testing facility center in our town. Yeah.
- 2:01:03Speaker 1: And it's where they helped develop the polio vaccine, right?
- 2:01:06Speaker 1: And they found out at one point that the vaccine
- 2:01:10Speaker 1: that they created was going to also could cause cervical
- 2:01:13Speaker 1: cancer in women. But they'd already made so much of
- 2:01:17Speaker 1: the vaccine that they still gave it out to women. They,
- 2:01:22Speaker 1: you know what I'm saying? Like, so I think I
- 2:01:23Speaker 1: was like, literally grew up in this environment where there
- 2:01:26Speaker 1: was always these like weird mysteries and things going on. Um, uh,
- 2:01:31Speaker 1: Lee Harvey Oswald went to the same middle school that
- 2:01:33Speaker 1: I went to, which was kind of wild. Um, so
- 2:01:36Speaker 1: there was just always like this, this allure in our
- 2:01:38Speaker 1: area of like, uh, I don't know if it's conspiracy
- 2:01:41Speaker 1: because now every conspiracy theory ends up being right about
- 2:01:43Speaker 1: two years later.
- 2:01:44Speaker 2: You probably read the book, right? That Mr. Dr.
- 2:01:46Speaker 1: Mary's monkeys.
- 2:01:46Speaker 2: Yeah.
- 2:01:47Speaker 1: Yeah. Yeah.
- 2:01:47Speaker 2: So that took place.
- 2:01:49Speaker 1: But it was just interesting to me because all I'd
- 2:01:52Speaker 1: heard about was this cures polio. But then also it
- 2:01:54Speaker 1: helps cause– it can contribute to causing cervical cancer in women.
- 2:01:58Speaker 1: So it just made me think out of the gate
- 2:01:59Speaker 1: like how reliable is what we're doing? That's something I've
- 2:02:03Speaker 1: always asked.
- 2:02:04Speaker 2: We should always trust but verify, understand what we're doing
- 2:02:10Speaker 2: now is very, very likely to change in the future.
- 2:02:14Speaker 2: Do you know most of the drugs I use now
- 2:02:16Speaker 2: didn't even exist when I went to medical school?
- 2:02:18Speaker 1: Wow.
- 2:02:19Speaker 2: So we get rid of old drugs. We use newer,
- 2:02:21Speaker 2: better drugs. We should have constant drug improvement. We should
- 2:02:25Speaker 2: have constant vaccine improvement. We talked about the measles vaccine.
- 2:02:28Speaker 1: That's a great point.
- 2:02:29Speaker 2: The measles vaccine has not been improved since the 1960s.
- 2:02:32Speaker 2: It's like, what?
- 2:02:34Speaker 1: That's crazy, dude.
- 2:02:35Speaker 2: It's nuts. I mean, there's been no improvement. And one
- 2:02:38Speaker 2: of the reasons why is the 1986 Vaccine Injury Compensation Act,
- 2:02:42Speaker 2: which gave immunity to any liability.
- 2:02:44Speaker 1: To the companies. That's why they couldn't face any lawsuits, right? Right.
- 2:02:46Speaker 2: So the companies have no incentives to make better safer products.
- 2:02:50Speaker 1: And not only not to make better ones, but to
- 2:02:53Speaker 1: save probably money on whatever they're currently manufacturing anyway, because
- 2:02:56Speaker 1: that's the way that business works a lot of times. Um,
- 2:02:59Speaker 1: why do you think that no politician wants to tackle
- 2:03:02Speaker 1: big pharma for real? You know, it's always this thing
- 2:03:05Speaker 1: that's kicked around, but it's, I mean, it's, it's, but
- 2:03:10Speaker 1: no one really does anything.
- 2:03:11Speaker 2: Well, remember, they don't want to touch healthcare. Remember, no
- 2:03:15Speaker 2: politician wants to touch Medicare, Medicaid, um, Drug companies, big pharma, vaccines.
- 2:03:22Speaker 2: Why don't they want to touch healthcare? The reason being
- 2:03:26Speaker 2: is that healthcare is about 17% of the gross domestic
- 2:03:30Speaker 2: national product. We spend more on GDP in healthcare than
- 2:03:33Speaker 2: any other country. It's big business. Do you know that
- 2:03:36Speaker 2: hospitals are the leading employer in most middle and smaller towns?
- 2:03:42Speaker 2: Healthcare is the leading employer of single mothers. Hmm. Healthcare
- 2:03:48Speaker 2: is so big. We spend so much money taking care
- 2:03:51Speaker 2: of each other. It's literally, it's a behemoth. And people
- 2:03:56Speaker 2: are afraid to touch it because it's such a political
- 2:03:59Speaker 2: hot potato. You do anything that looks like you're anti-healthcare, anti-vaccine,
- 2:04:04Speaker 2: anti-drug company, anti-nurses or anti-doctors, you're going down. You're not
- 2:04:08Speaker 2: getting reelected.
- 2:04:08Speaker 1: I mean, and if you're a regular person, it's like
- 2:04:10Speaker 1: you won't even work. If 17% of our GDP is
- 2:04:12Speaker 1: going through that canal, it's like a lot of people
- 2:04:15Speaker 1: would be afraid to speak up because they wouldn't even
- 2:04:17Speaker 1: be able to work.
- 2:04:17Speaker 2: Oh, I'm wrong.
- 2:04:18Speaker 1: It's 18.5. Healthcare spending accounted for about 18.5% of U.S.
- 2:04:22Speaker 1: GDP in 2025. If we can't change it, how do
- 2:04:27Speaker 1: you avoid big pharma, do you feel like?
- 2:04:29Speaker 2: You know, I've been impressed in the last six years,
- 2:04:35Speaker 2: and I'm constantly collaborating, and I've always done this my
- 2:04:38Speaker 2: entire life. So I'm literally out of the medical orthodoxy now.
- 2:04:43Speaker 2: I was the named endowed professor lecturer at Harvard in 2019.
- 2:04:49Speaker 2: Harvard hasn't invited me back. I was a full professor
- 2:04:52Speaker 2: of medicine where I was in Dallas, Texas. So I'm
- 2:04:55Speaker 2: now actually working with naturopathic and holistic and other doctors.
- 2:05:00Speaker 2: And one of them has particularly impressed me where he said, listen,
- 2:05:04Speaker 2: he said, it's nature first, drugs last. So try to
- 2:05:10Speaker 2: find natural solutions. And if you're willing to do this,
- 2:05:14Speaker 2: that means you probably will be taking more supplements or
- 2:05:19Speaker 2: vitamins than you normally would. It probably means you'll pay
- 2:05:23Speaker 2: more attention to diet and exercise than you normally would.
- 2:05:27Speaker 2: But you are intentionally not going to have a reliance
- 2:05:30Speaker 2: on drugs.
- 2:05:31Speaker 1: Yeah. Yeah. And have some responsibility for ourselves. Yeah. I mean,
- 2:05:34Speaker 1: it almost did. I get to the point in my
- 2:05:36Speaker 1: life where it feels gross even Like, I mean, recreational
- 2:05:40Speaker 1: drugs now, that's different. But if I just have to
- 2:05:42Speaker 1: take a pill for something, it just feels so cringe
- 2:05:46Speaker 1: to me now. Even opening a pill bottle, it just
- 2:05:49Speaker 1: feels like it has such a sour taste in the world,
- 2:05:53Speaker 1: I think, for a lot of people these days. But
- 2:05:56Speaker 1: it also saves people's lives. There's also a lot of.
- 2:05:58Speaker 2: Great medicines out there. Well, let me ask you this.
- 2:06:01Speaker 2: What percent of people make it to age 80 perfectly
- 2:06:05Speaker 2: healthy without relying on any drugs?
- 2:06:10Speaker 1: Probably none.
- 2:06:10Speaker 2: About 10%. It's possible.
- 2:06:12Speaker 1: Okay.
- 2:06:13Speaker 2: It's possible. I'm not one of them. I'm 63 years old.
- 2:06:18Speaker 2: I've had high blood pressure since age 25. I mean,
- 2:06:20Speaker 2: life-threatening high blood pressure. I can't live without taking a
- 2:06:23Speaker 2: blood pressure pill every day. So I'm not going to
- 2:06:25Speaker 2: make it.
- 2:06:26Speaker 1: This helps.
- 2:06:26Speaker 2: I'm not going to make it. Yeah, well, I take
- 2:06:28Speaker 2: some natural products as well. But the point is- I
- 2:06:32Speaker 2: have people come to my office saying, doc, I don't
- 2:06:34Speaker 2: want to take any medicines. I had somebody like that yesterday.
- 2:06:37Speaker 2: He's already had a heart attack. He has stents in
- 2:06:39Speaker 2: his coronary artery. I said, well, we're going to do
- 2:06:42Speaker 2: the best we can with the natural products. But, you know,
- 2:06:43Speaker 2: I got to tell you, if I was you, I
- 2:06:45Speaker 2: would take the prescription drugs. A lot of prescription drugs
- 2:06:48Speaker 2: are natural anyway. And they're just in purified form. Like
- 2:06:52Speaker 2: aspirin is over the counter, but it's a drug. It's
- 2:06:56Speaker 2: derived from the bark of birch trees. Hydroxychloroquine, which we
- 2:07:01Speaker 2: used in COVID, but we used for malaria and for
- 2:07:03Speaker 2: rheumatoid arthritis, that's derived from the bark of a chinchona tree.
- 2:07:08Speaker 2: Ivermectin is derived from the soil in Japan. It's produced
- 2:07:11Speaker 2: by another organism.
- 2:07:14Speaker 1: Those two drugs specifically, hydrochloroquine and ivermectin, got such a
- 2:07:17Speaker 1: bad rap. If you read Bobby Kennedy's book about Dr. Fauci,
- 2:07:22Speaker 1: it lays out how some of that was pre-planned, how
- 2:07:26Speaker 1: it was... how it was lobbied against in certain environments.
- 2:07:30Speaker 1: It was taken off the shelves. When you look back
- 2:07:32Speaker 1: on those two medicines, what are your thoughts about them?
- 2:07:35Speaker 2: You know, I think that those who really, really were
- 2:07:42Speaker 2: involved in pandemic planning, even in the Johns Hopkins 2017
- 2:07:49Speaker 2: sparse pandemic training exercise, there was a drug proposed. and
- 2:07:55Speaker 2: it was going to generate confusion. And in the planning exercise,
- 2:07:58Speaker 2: they kill the drug to feature the vaccine. That was
- 2:08:01Speaker 2: in 2017 in the open. I think it was essentially
- 2:08:05Speaker 2: in people's minds to say, listen, don't allow any drugs
- 2:08:10Speaker 2: to play a role here. We want to feature mass
- 2:08:13Speaker 2: vaccination as the principle. So hydroxychloroquine killed in the first year.
- 2:08:19Speaker 2: Second year, ivermectin killed. We had IV monoclonal antibodies, high-tech
- 2:08:24Speaker 2: operation warp speed. They were safe and effective. I used
- 2:08:26Speaker 2: them like crazy. They were taken off the market rapidly,
- 2:08:28Speaker 2: six in a row taken off the market. Colchicine, super useful. Again,
- 2:08:32Speaker 2: natural product, but it's a prescription drug. It was absolutely
- 2:08:36Speaker 2: suppressed and crushed. Corticosteroids were great confusion over those. They
- 2:08:41Speaker 2: were suppressed. Vitamin D, Eric Naputi, who ran a company,
- 2:08:47Speaker 2: the Federal Trade Commission sued him and his company personally.
- 2:08:50Speaker 2: Nasal sprays and gargles, they worked very well in reducing
- 2:08:54Speaker 2: the viral burden. Nate Jones at Clear personally and his
- 2:08:58Speaker 2: company was sued by the Federal Trade Commission. He was crushed.
- 2:09:01Speaker 2: For what?
- 2:09:02Speaker 1: What was he crushed for?
- 2:09:03Speaker 2: For creating them? He was crushed for proposing that we
- 2:09:07Speaker 2: could use them in the pandemic.
- 2:09:10Speaker 1: People forget so quick. Remember, have you mentioned anything Everybody
- 2:09:14Speaker 1: was against you. It could be your neighbor. It was
- 2:09:16Speaker 1: like the news channels. This guy disagrees.
- 2:09:20Speaker 2: Except the vaccine. You weren't crushed if you said the
- 2:09:23Speaker 2: vaccine's the answer.
- 2:09:24Speaker 1: Oh, for sure.
- 2:09:26Speaker 2: But it's interesting. That was in the minds of people.
- 2:09:28Speaker 2: So nasal sprays and gargles, vitamin D, other forms of nutraceuticals, hydroxychloroquine, ivermectin,
- 2:09:34Speaker 2: monoclonal antibodies, colchicine, corticosteroids. The entire McCullough protocol was crushed.
- 2:09:40Speaker 2: It didn't matter if it was cheap generic or expensive.
- 2:09:43Speaker 2: high tech. That told you there was some type of
- 2:09:46Speaker 2: delusion about the vaccine being the only approach. Remember Paxlovid,
- 2:09:54Speaker 2: the oral drug that comes in, comes in two years
- 2:09:57Speaker 2: into the pandemic. In the first year, all we really
- 2:10:00Speaker 2: had was McCulloch protocol and hydroxychloroquine. The second year, we
- 2:10:03Speaker 2: really had McCulloch protocol and ivermectin. So it got so bad,
- 2:10:07Speaker 2: the FDA put out You know, flagrantly false information about
- 2:10:13Speaker 2: ivermectin on its website and on Twitter, all over. Misleading information.
- 2:10:18Speaker 2: The FDA is sued by three doctors. And this goes
- 2:10:22Speaker 2: through court proceedings. And finally, the FDA says, we'll take
- 2:10:25Speaker 2: down our false information. Why is our FDA putting out
- 2:10:30Speaker 2: false information on ivermectin? It was hurting people. I'm telling
- 2:10:35Speaker 2: you as a doctor, and again, I have the authority
- 2:10:36Speaker 2: to make this call. I've used it. I've looked at
- 2:10:39Speaker 2: all the clinical trials. I understand clinical trials very well.
- 2:10:42Speaker 2: I'm telling you, ivermectin is safe and effective.
- 2:10:45Speaker 1: I mean, I've done a lot of drugs over the years.
- 2:10:46Speaker 1: I'd do a little probably. Was there anybody who was
- 2:10:52Speaker 1: immune to any genetics or demographics or cultures that were
- 2:10:58Speaker 1: immune to COVID-19?
- 2:11:00Speaker 2: There were a few papers indicating that children were largely immune,
- 2:11:04Speaker 2: that they had a lot of cross-exposure with other coronaviruses.
- 2:11:08Speaker 2: almost no serious cases in children. There was an occasional
- 2:11:11Speaker 2: child with cystic fibrosis or some problem who got really sick,
- 2:11:14Speaker 2: but children are largely immune. School teachers, because they have
- 2:11:17Speaker 2: so much, there was no significant spread of serious illness
- 2:11:22Speaker 2: from children to the school teachers.
- 2:11:24Speaker 1: But no, was there any like, was there any like
- 2:11:26Speaker 1: a Norwegian person couldn't get it? Or was there like
- 2:11:29Speaker 1: somebody from Zimbabwe? Like, was there any like.
- 2:11:31Speaker 2: A, There's one adult group, you're going to laugh, but
- 2:11:34Speaker 2: there's one adult group, no specific ethnicity or culture, but
- 2:11:38Speaker 2: you're going to laugh, smokers.
- 2:11:41Speaker 1: Smokers couldn't get it?
- 2:11:42Speaker 2: They got it, very mild cases. And they don't get
- 2:11:46Speaker 2: long COVID. You know why?
- 2:11:49Speaker 1: Why?
- 2:11:50Speaker 2: Because smokers maintain a level of nicotine in the bloodstream.
- 2:11:55Speaker 2: They actually smoke frequently enough, blood nicotine blocks the spike
- 2:11:59Speaker 2: protein as it's interfacing with a nicotinic acetylcholine receptor. Smoking
- 2:12:06Speaker 2: blocks the spike protein. It's amazing. I thought smokers were
- 2:12:11Speaker 2: going to go down.
- 2:12:12Speaker 1: Well, who knows now then all those years of this,
- 2:12:14Speaker 1: all those smoking advertisements ended up probably saving people's lives
- 2:12:17Speaker 1: 40 years later.
- 2:12:18Speaker 2: Well, you know what we use now use, we use
- 2:12:21Speaker 2: a nicotine patch, seven milligram patch, even in non-smokers to
- 2:12:26Speaker 2: help them through long COVID. We use it in addition
- 2:12:28Speaker 2: to the McCullough protocol.
- 2:12:30Speaker 1: I've seen people recommend that people should just be on
- 2:12:31Speaker 1: nicotine of like a take a nicotine pass. Do you
- 2:12:33Speaker 1: think that's a good idea on a regular basis or
- 2:12:35Speaker 1: is that just?
- 2:12:36Speaker 2: I think if they have long COVID, I recommended to
- 2:12:37Speaker 2: a patient yesterday, if they have long COVID symptoms, nicotine,
- 2:12:42Speaker 2: don't forget, is a nootropic. A nootropic is a drug
- 2:12:48Speaker 2: that does make the brain function more effectively. It's a methylxanthine.
- 2:12:53Speaker 2: It's related to caffeine. Caffeine does the same thing. It's
- 2:12:55Speaker 2: an nootropic. So some people use nicotine little packets or whatever.
- 2:12:59Speaker 2: I grew up in Texas. So, you know, there were
- 2:13:02Speaker 2: kids were dip snuffing.
- 2:13:03Speaker 1: Oh, yeah. We used to chew that plug tobacco. Right.
- 2:13:06Speaker 2: My dad was a chain smoker. But nicotine itself is addictive,
- 2:13:12Speaker 2: but it's not harmful to the human body. And so is,
- 2:13:14Speaker 2: by the way, caffeine is addictive, but it's not harmful
- 2:13:17Speaker 2: to human body. What's harmful is... is the tars that's
- 2:13:21Speaker 2: in tobacco and smoke. So you might even use the
- 2:13:24Speaker 2: dip snuff that's related to oral cancer. But now the
- 2:13:26Speaker 2: purified forms of nicotine, my understanding is that they're safe.
- 2:13:29Speaker 2: The nicotine patches are perfectly safe. And there you go.
- 2:13:34Speaker 1: Nicotine is a cognitive enhancer. Right before we started, I
- 2:13:38Speaker 1: heard you say that The past six years have been
- 2:13:40Speaker 1: very exciting in your life, right? Because it seems like,
- 2:13:44Speaker 1: does it feel like now that you have more of
- 2:13:46Speaker 1: a sense of purpose, that you've kind of been put
- 2:13:49Speaker 1: at the pinnacle of this, like being somebody to raise
- 2:13:53Speaker 1: their hand about, hey, is this safe for us? Because
- 2:13:59Speaker 1: so often people look back, you look at movies that
- 2:14:04Speaker 1: champion a certain person, And at first that person was
- 2:14:07Speaker 1: ridiculed and ostracized, you know, that's always the story, but
- 2:14:11Speaker 1: it's so crazy. And then at the end, they're the champion.
- 2:14:14Speaker 1: And we lulled them as being like, thank God they
- 2:14:17Speaker 1: brave the rapids and they did this. But then we'll
- 2:14:20Speaker 1: see somebody in our present lives who are trying to
- 2:14:23Speaker 1: do the same thing. And whether they're right or wrong,
- 2:14:26Speaker 1: sometimes it's like, I'm always like, That person's trying to
- 2:14:31Speaker 1: do something different, right? Like that person is speaking against
- 2:14:35Speaker 1: the grain. Don't you think of all the movies that
- 2:14:38Speaker 1: we've seen where it's like that's the beginning of the story?
- 2:14:42Speaker 1: So I know that like the last six years of
- 2:14:44Speaker 1: your life have been wild. You said that. What did
- 2:14:47Speaker 1: you mean when you said that? And have you just
- 2:14:48Speaker 1: felt a lot more of a sense of purpose? Do
- 2:14:50Speaker 1: you feel more support now than you did in the beginning?
- 2:14:53Speaker 1: Tell me some of that before we get you out
- 2:14:55Speaker 1: of here. And thank you so much.
- 2:14:57Speaker 2: The last six years of my life called me to
- 2:14:59Speaker 2: essentially adopt an entirely new area of medicine, which is
- 2:15:04Speaker 2: infectious diseases and specifically the pandemic and everything about it,
- 2:15:11Speaker 2: but has also, in a sense, thrust me into the
- 2:15:15Speaker 2: public limelight as a figure and You'll be the first
- 2:15:19Speaker 2: one to tell people, I didn't ask to come on
- 2:15:21Speaker 2: your show. No, no, not at all. We were excited.
- 2:15:23Speaker 2: I didn't ask to go on Joe Rogan, and I
- 2:15:26Speaker 2: didn't ask to go testify in the U.S.
- 2:15:28Speaker 3: Senate.
- 2:15:29Speaker 2: I'm being called to play a role in this enormous
- 2:15:35Speaker 2: controversy that's unfolded in the world. And sadly, people did
- 2:15:40Speaker 2: die of the infection, and even more people have died
- 2:15:44Speaker 2: of the vaccine now. And we still haven't seen this
- 2:15:47Speaker 2: whole story unfold. There seems to be a groupthink, a
- 2:15:53Speaker 2: madness that we saw evolve regarding fear, masks, lockdowns, hand sanitizer, vaccines.
- 2:16:03Speaker 2: We don't know what's coming next, but I can tell
- 2:16:06Speaker 2: you this infectious groupthink, it does occur among doctors and
- 2:16:11Speaker 2: nurses and healthcare professionals. I think they're very susceptible to this.
- 2:16:15Speaker 2: Something has happened in the human mind and we need...
- 2:16:18Speaker 2: We need to have a lot more discussion on this.
- 2:16:21Speaker 2: We have to be able to call meetings and have
- 2:16:25Speaker 2: people come together. If our government can do anything, they
- 2:16:28Speaker 2: just have to bring together the orthodoxy, those who are
- 2:16:34Speaker 2: the innovators and the thinkers outside. Remember in the time
- 2:16:37Speaker 2: of a controversy and a crisis, the answer never comes
- 2:16:43Speaker 2: from within us. the establishment, never, never. Previously, the establishment
- 2:16:48Speaker 2: for centuries and centuries was the church. And when there's
- 2:16:51Speaker 2: a crisis, the church didn't provide a solution. You can
- 2:16:54Speaker 2: tell governments all over the world did not provide a
- 2:16:57Speaker 2: solution to the pandemic, but individuals did. And fortunately, a
- 2:17:01Speaker 2: wellness company, we got like-minded people. We formed an entire company.
- 2:17:04Speaker 2: We've been very successful, but here we are. So I
- 2:17:09Speaker 2: must have been called to play a role in this
- 2:17:12Speaker 2: time of great controversy. It's been so great to be
- 2:17:14Speaker 2: on your show.
- 2:17:14Speaker 1: Yeah. Dr. McCullough, thank you so much. And thank you
- 2:17:16Speaker 1: so much for just being brave enough to speak up
- 2:17:18Speaker 1: and to think out loud. Like that's what we, you know,
- 2:17:22Speaker 1: it's like so many times during this conversation, I've just
- 2:17:25Speaker 1: realized like how we slowly just get like molded into the,
- 2:17:29Speaker 1: like kind of folded into the batter. We don't even
- 2:17:31Speaker 1: realize it, you know? So yeah. Thank you so much
- 2:17:34Speaker 1: for joining us today.
- 2:17:35Speaker 2: Yep.
- 2:17:36Speaker 1: I'm going to grab something from the wellness company and yeah,
- 2:17:38Speaker 1: I'd love to chat again sometime and see how things
- 2:17:40Speaker 1: are going.
- 2:17:40Speaker 2: All right. Thanks for having me.
- 2:17:43Speaker 3: On the breeze and I feel I'm falling like these
- 2:17:47Speaker 3: leaves I must be corners oh but when i reach
- 2:17:54Speaker 3: that ground i'll share this peace of mind i found
- 2:17:58Speaker 3: i can feel it in my bones